Introduction {#s1}
============

Experiments such as nuclear transfer and reprogramming of differentiated fibroblasts into pluripotent cells (iPS) have changed the classical view of a rigid 'terminally-differentiated' cell state to a more plastic one ([@bib41]; [@bib91]; [@bib68]), suggesting that once established, differentiated cells must actively maintain their identities ([@bib11]; [@bib69]; [@bib45]; [@bib10]). Indeed, failure to maintain a differentiated identity is associated withn altered physiological properties of post-mitotic cells and tissues, resulting in disease such as diabetes, neurodegeneration, and cancer ([@bib24]; [@bib71]; [@bib83]). Moreover, recently it was shown that loss of identity is a hallmark of the aging *Drosophila* midgut ([@bib58]).

Differentiated cells maintain their identity by multiple mechanisms, including tissue-specific transcription factors (TFs) and the control of high-order chromatin structure (e.g., [@bib22]; [@bib69]; [@bib45]; [@bib59]). Additionally, nuclear lamins are essential in establishing a nuclear organization that is unique to the differentiated state ([@bib55]; [@bib37]). These mechanisms likely serve as a barrier against pathological reprograming and are highly relevant to human disease and regenerative medicine. While differentiated cells exhibit distinct chromatin and nuclear organization, the mechanisms by which identity supervisors establish, maintain, and orchestrate these multi-levels of identity regulation are less clear.

One tissue used to study how differentiated cells maintain their identity in the context of a highly regenerating tissue in vivo is the *Drosophila* adult gut epithelium ([Figure 1A](#fig1){ref-type="fig"}; [@bib57]; [@bib40]). Intestinal stem cells (ISCs) proliferate within the adult gut epithelia of both flies and vertebrates to either self-renew or differentiate into mature differentiated gut cells. Differentiated gut cells are characterized by functional diversity and a short lifespan ([@bib52]; [@bib70]). One of the most studied *Drosophila* gut regions is the midgut, which is further divided into sub-regions. While each sub-region has specific characteristics, key regulatory principles are common along the entire midgut ([@bib64]; [@bib27]). In the midgut epithelium, intestinal stem cells (ISCs) either self-renew or mature into enteroblasts (EBs, [Figure 1A](#fig1){ref-type="fig"}; [@bib65]; [@bib72]), which in turn differentiate into large absorptive polyploid enterocytes (ECs). A smaller population of ISCs differentiate into secretory enteroendocrine cells (pre-EE and subsequently EEs; [@bib4]; [@bib40]; [@bib81]). As in vertebrates, *Drosophila* midgut homeostasis requires extensive signaling between different epithelial gut cells as well as crosstalk with cells in neighboring tissues. Well-conserved signaling pathways, such as Notch, Wnt, EGF, Jak-Stat, and JNK, govern stem cell differentiation and are activated by diverse physiological changes, such as regeneration upon injury or response to infection ([@bib8]; [@bib51]; [@bib30]). During aging, gut homeostasis is impaired, resulting in aberrant signaling, loss of EC physiology, and mis-differentiation of progenitor cells ([@bib8]; [@bib78]; [@bib15]; [@bib58]; [@bib66]).

![*Drosophila* Hey is required for maintaining EC identity.\
(**A**) Schematic diagram of major *Drosophila* midgut cell types. ISC, intestinal stem cell; EB, enteroblast; EC, enterocyte; Pre-EE, enteroendocrine progenitor, EE enteroendocrine cell. (**B--I'**) Confocal images of adult *Drosophila* midgut intestinal epithelium expressing the indicated transgenes, scale bar is 10 μm. Arrows indicate cells shown in insets. (**B--D**) Endogenous Hey protein was identified using an α-Hey antibody (red). The expression of UAS-GFP under the control of *Delta*-Gal4 (**B**), *Su(H)*-Gal4 (**C**), and *prospero*-Gal4 (**D**) mark ISCs, EBs, and EEs, respectively. (**E--I'**) Confocal images of control cells (**E--F'**) or midguts in which Hey was targeted for 48 hr in ECs using the indicated RNAi transgenic lines (**G--I'**). α-Delta (red E-E' G-G' I-I'), *MyoIA*^ts80^ \>GFP (green) and anti-PDM1(red, (**F, F', H, H'**) mark differentiated ECs; DAPI marks DNA (blue). White dashed circles in (**H**) are Pdm1-negative polyploid cells indicated in H' by white arrows. (**J, J'**) Quantification of total cell number per region of interest (**J**), and polyploid cells that express Delta and are GFP negative in experimental setting similar to G, G' and I, I';(**J\'**) \*\*\*\*p\<0.0001, \*\*\*p\<0.001, \*p\<0.05. (**K--N**) Hey depletion for 48 hr in ECs results in activation of stress and regeneration pathways; ectopic activation of JAK-STAT reporter (**K, L**) (*10XSTAT*::GFP reporter, GFP) and Notch pathway reporter in polyploid cells (**M, N**) (*ghd3*::LacZ reporter; RFP). White arrows point to cells shown in the inset.\
10.7554/eLife.44745.007Figure 1---source data 1.Quantification of average number off cells in control and guts where Hey is targeted in EC data related to [Figure 1](#fig1){ref-type="fig"}.Quantification data related to [Figure 1J](#fig1){ref-type="fig"} -- Average number of cells per ROI. Quantification data related to [Figure 1J\'](#fig1){ref-type="fig"} --number of PPC Dl(+)GFP(-).](elife-44745-fig1){#fig1}

A central pathway that regulates ISC differentiation and gut homeostasis is the Notch pathway, which plays multiple roles in the midgut ([@bib13]). High levels of Notch activity are required for ISC differentiation and the acquisition of an EC fate. Part of the Notch activity is mediated by the evolutionarily conserved HES (hairy/enhancer of split) and HES-related bHLH-transcription factors. In progenitor cells, HES limits ISC self-renewal and promotes differentiation by inhibiting the expression of the Notch ligand, Delta ([@bib1]; [@bib75]). Here we report that *Drosophila* Hey, a HES-related transcription factor, is a critical supervisor of ECs\' differentiated identity ([@bib67]; [@bib39]; [@bib46]). In vertebrates, Hey proteins (Hey1, Hey2, HeyL) regulate cell fate decisions during cardiogenesis, angiogenesis, and neurogenesis, as well as within the immune system ([@bib44]; [@bib97]). The *Drosophila* genome encodes a single Hey protein (CG11194) that is required for embryonic development and larval neurogenesis ([@bib61]; [@bib67]; [@bib100]). While a wealth of data has accumulated on Hey protein function during development, little is known regarding its function in differentiated cells within adult tissues. We found that Hey supervises the identity of fully differentiated ECs in the adult midgut by continued regulation of nuclear lamins expression. In concert with Lamin C (LamC, *Drosophila* A-type lamin), Hey maintains a nuclear architecture unique to the differentiated ECs. Moreover, misexpression of nuclear lamins in non-relevant cells overrides the endogenous cell identity programs. Remarkably, the level of Hey in ECs decline with aged and forced expression of Hey in aged ECs restores ECs identity, suppressing aging phenotypes. Thus, the continued supervision of chromatin and nuclear organization by Hey is critical for maintaining cell identity, tissue homeostasis, and organismal survival.

Results {#s2}
=======

Hey is required to maintain the differentiated state of ECs {#s2-1}
-----------------------------------------------------------

Our initial step in assessing the role(s) of Hey in adult intestinal epithelia was to determine the protein expression of endogenous Hey in the gut epithelia cells using an anti-Hey antibody together with cell-specific GFP reporters and cell-specific markers ([Figure 1B--D](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1K--P](#fig1s1){ref-type="fig"}; [@bib67]). We found that Hey protein is expressed in ISCs, EBs, EEs and is abundant in fully differentiated ECs, suggesting a functional role for Hey in ECs.

To address the function of Hey proteins in fully differentiated gut cells, we conditionally and temporally knocked down Hey in either ECs or EEs in 2--4 days old adult *Drosophila* females using several independent UAS-Hey-RNAi lines, under the control of cell-specific Gal4/Gal80^ts^ coupled systems (see Materials and methods and figures for specific lines used; [@bib82]; [@bib12]). We used tub-Gal80ts; *MyoIA-*Gal4 (termed MyoIA^ts^) to target Hey in ECs;, and the *Prospero-*Gal4; tub-Gal80^ts^ to target Hey in EEs ([@bib15]). RNAi knockdown of Hey in ECs and EEs had no detectable effect on either EE number or differentiation state, as indicated by the expression of the EE-related transcription factor Prospero ([Figure 1](#fig1){ref-type="fig"}-figure - However, upon conditional inactivation of Hey in adult ECs, expression of an EC marker *MyoIA*::GFP and the EC founder homeobox transcription factors Pdm1 and Odd-skipped (Odd) were reduced throughout the entire midgut (compare [Figure 1E--F'](#fig1){ref-type="fig"} with 1 G-H', [Figure 1---figure supplement 1A--B'](#fig1s1){ref-type="fig"}, and quantified in [Figure 1---figure supplement 1E,F](#fig1s1){ref-type="fig"}; [@bib56]; [@bib27]).

A second prominent phenotype was hyperplasia of intestinal epithelial cells, doubling the number of cells upon loss of Hey in EC ([Figure 1I--J'](#fig1){ref-type="fig"}). A third phenotype was the ectopic expression of the Notch ligand Delta, which is normally expressed only in ISCs and immature EE cells ([Figure 1J,J'](#fig1){ref-type="fig"}). This ectopic Delta expression was observed on the surface of large polyploid cells resembling ECs, in part not expressing *MyoIA*::GFP ([Figure 1G--I'](#fig1){ref-type="fig"} and quantified 1J, J'; [@bib40]). These cells, however, did not express the EE marker Prospero, suggesting that they did not transdifferentiate to EEs ([Figure 1---figure supplement 1G,H](#fig1s1){ref-type="fig"}). The loss of MyoIA::GFP expression, ectopic Delta expression and overall gut morphology phenotypes were also observed in males, along the entire midgut ([Figure 1---figure supplement 2A--D'](#fig1s2){ref-type="fig"}), and were suppressed by over-expression of UAS-Hey, but not by a control transgene, ([Figure 1---figure supplement 1C,C'](#fig1s1){ref-type="fig"}). Moreover, RNAi knockdown of Notch, Suppressor of Hairless (Su(H)), other HES TFs, and HES-related cofactors did not phenocopy Hey loss in ECs ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}) RNA-mediated knockdown of Hey in ECs not only impaired EC identity but also affected the entire epithelial tissue and gut homeostasis. Using pathway-specific reporter transgenes, we observed that loss of Hey in ECs resulted in hyper-activation of stress and regeneration-related pathways such as JAK/STAT and Notch including in polyploid cells (PPCs) in which these pathways are normally silent ([Figure 1K--N](#fig1){ref-type="fig"} and see also Figure 6). Thus, we conclude that maintaining EC identity and tissue homeostasis requires continuous Hey expression in ECs.

Hey loss in ECs impairs EC identity and progenitor differentiation {#s2-2}
------------------------------------------------------------------

We hypothesized that the above-mentioned phenotypes may originate either from inability of ECs to maintain differentiated identity, and/or due to activation of stress response of ISCs resulting in enlarged progenitors, that fail to fully differentiate into ECs in the absence of Hey ([@bib84]). Therefore, to determine the fate of individually targeted ECs and to assess the cellular composition of the gut upon Hey loss in ECs, we used 'G-TRACE', a method for lineage tracing of non-dividing cells ([Figure 2A](#fig2){ref-type="fig"}, see Materials and methods; [@bib29]). In brief, a UAS-RFP marker is expressed via the EC-specific promoter/driver *MyoAI-*Gal4, which is active only in fully differentiated ECs (red). The same *MyoIA-*Gal4 also drives the expression of a UAS-flipase that induces a recombination event that activates permanent GFP expression, which serves as a 'history marker'. This GFP 'history marker' is expressed in fully differentiated ECs and their progeny regardless of the cell's current differentiation state. Indeed, [all]{.ul} ECs in control guts were both RFP and GFP positive (RFP^+^, GFP^+^) and appeared orange ([Figure 2B](#fig2){ref-type="fig"}, and quantitated in 2F). In contrast, twenty-four and forty-eight hours after Hey targeting in ECs, we observed diverse fluorescence populations of polyploid cells (PPCs; [Figure 2C--F](#fig2){ref-type="fig"}, and dynamic analysis is shown in [Figure 2---figure supplement 1A--A""](#fig2s1){ref-type="fig"}): After forty-eight hours 48% of PPCs expressed both RFP^(+)^, and GFP^(+)^ (similar to control EC, [Figure 2C1](#fig2){ref-type="fig"}). 37% expressed only GFP, but not RFP (PPC^GFP(+),\ RFP(-)^ termed PPC\*\*; [Figure 2C](#fig2){ref-type="fig"}'2). We also observed 11% PPCs that were negative for both RFP and GFP (PPC ^GFP(-),\ RFP(-)^) and were characterized by large, polyploid nuclei (termed PPC\*; [Figure 2C](#fig2){ref-type="fig"}'3). Finally, we detected few (4%) PPCs that were RFP^(+)^, GFP^(-)^; [Figure 2C](#fig2){ref-type="fig"}'4), likely reflecting ECs in which the recombination event did not take place. By the nature of the G-TRACE tracing lineage system we suggest that PPC are highly similar to control ECs, PPC\*\* are former ECs that no-longer express the MyoIA \>RFP and are likely former EC that no longer maintain EC identity. Likely PPC\* are rapidly developing mis-differentiated progenitors/young PPCs that did not activate the marking system. Using G-TRACE, we further characterized the properties of the different PPCs. We found that PPC\*\* cells as well as PPC\* ectopically expressed the ISC marker Delta ([Figure 2E,E'](#fig2){ref-type="fig"}). Moreover, PPC\*\* did not express the enterocyte founder transcription factor Pdm1, nor they express EC-specific genes like Odd-skipped and Snakeskin, a septate junction-related protein ([Figure 2G--I'](#fig2){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}; [Supplementary file 2](#supp2){ref-type="supplementary-material"}; [@bib56]; [@bib27]). In addition, the overall ploidy of PPCs cells was only minimally affected ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). Based on the nature of the G-TRACE system, these data suggest that Hey depletion in ECs resulted in EC that can no longer maintain EC identity (PPC\*\*).

![Gut analyses using G-TRACE lineage tracing of ECs.\
(**A**) Illustration of G-TRACE lineage tracing (adopted from [@bib29]). (**B--E'**) Confocal images of G-TRACE analyses of control (**B**) and Hey-targeted ECs (**C--E'**). (**B**) All ECs in control guts co-express *MyoIA*-Gal4 \>UAS RFP, and the history marker Ub::GFP, and are denoted in orange \[GFP ^(+)^ RFP ^(+)^\]. (**C--D**) A heterogeneous population of polyploid cells is observed in midguts in which Hey is targeted in ECs for 48 hr using the indicated Hey-RNAi transgenic lines. Numbered white arrows in C point to cells shown in C': Differentiated ECs (C'1, GFP^(+)^, RFP^(+)^); PPC\*\*, C'2, GFP^(+)^RFP^(-)^); PPC\*, C'3, GFP^(-)^ RFP^(-)^); Enterocytes in which GFP-activating recombination has not taken place (PPC^R^ C'4, GFP^(-)^RFP^(+)^). DAPI marks DNA (blue). (**E, E'**) PPC\* and PPC\*\* ectopically express Delta. (**E'**) IMARIS-assisted 3D reconstruction of the area indicated in E by a yellow square. A PPC\*\* is indicated by a white arrow in E' and is shown in the inset of E. (**F**) G-TRACE-based quantification of polyploid cells after 48 hr; four independent biological repeats (n = 350, results shown are mean ± SD). (**G--J'**) G-TRACE-analyses of ECs (**G, H, I, J**) and PPC\*\* (G' H' I' J'). The indicated protein is shown in pink; (**G, G'**), Pdm1; (**H, H'**), Odd-skipped; (**I, I'**), SSK; (J J') p-Histone-H3. DAPI marks DNA (blue). (**K--N**) Expression of the *escargot* progenitor enhancer reporter M5-4-LacZ (**K, L**) and neuronal marker 22C10 (**M, N**) in control or Hey-targeted ECs analyzed by G-TRACE, and see quantification [Figure 4---figure supplement 3E](#fig4s3){ref-type="fig"}.\
10.7554/eLife.44745.011Figure 2---source data 1.Quantification data related to [Figure 2F](#fig2){ref-type="fig"}- % of PPC (EC/PPC^\*\*^/PPC^\*^/PPC^R^).](elife-44745-fig2){#fig2}

Transcriptional regulation of EC identity by Hey {#s2-3}
------------------------------------------------

The inability to supervise EC identity is likely due to a failure in maintaining a Hey-related transcriptional program. We therefore used gene expression arrays to determine the transcription signature of whole guts upon targeting Hey in ECs using MyoIA-Gal4 and UAS-Hey RNAi. We also determined Hey-regulated genes in progenitors by comparing the gene signature of affinity-purified progenitors expressing either UAS-GFP (control) or UAS-Hey RNAi. Activation of the UAS-transgenes in progenitors was driven by *hey*-Gal4, which is expressed predominantly in EBs, minimally in ISC, and not at all in ECs and EEs. ([Figure 3---figure supplement 1A--F'](#fig3s1){ref-type="fig"}, and see below and Materials and methods).

Upon Hey knockdown in ECs, we identified 370 differentially expressed genes (DEGs) whose expression in the gut is Hey dependent (termed 'Hey-regulated genes'; [Supplementary file 1](#supp1){ref-type="supplementary-material"}, for PCA plots see [Figure 3---figure supplement 4D,E](#fig3s4){ref-type="fig"}), and see Materials and methods). Note that \~50% (113/228) of genes exhibiting reduced expression upon Hey targeting in ECs are genes that are repressed by the ectopic expression of the progenitor transcription factor Escargot (Esg) in ECs suggesting that they are EC-related ([Figure 3---figure supplement 1G](#fig3s1){ref-type="fig"}, [Supplementary file 5](#supp5){ref-type="supplementary-material"}; [@bib53]). Overall, the transcriptional signature of guts in which Hey knockdown was induced in ECs largely resembled the transcriptional signature of control purified progenitors (see below [Figure 3A,A'](#fig3){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}). Gene ontology analyses revealed that Hey maintains a differentiated EC gene signature. It is required for the expression of numerous genes involved in EC physiology and metabolism, and numerous putative digestive enzymes such as genes involved in lipid transporters, lipase activity, amino acid metabolism, and peptidases ([Figure 3B](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1Q](#fig3s1){ref-type="fig"}, [Supplementary file 2](#supp2){ref-type="supplementary-material"}; [Supplementary file 6](#supp6){ref-type="supplementary-material"}, <https://flygut.epfl.ch/expressions>).

![Transcriptional analysis of targeting Hey in ECs.\
(**A--A'**) Heat map depicting changes in gene expression in control guts, enriched purified progenitors (Ps^isolated^), and guts in which Hey is targeted in ECs for 48 hr (Gut EC^Heyi^). (**A**) Genes repressed upon Hey targeting in ECs, and (**A'**) genes activated upon Hey targeting in ECs. (**B, C**) Cytoscape-based gene-ontology analyses for genes that are downregulated or upregulated, respectively, upon Hey depletion in ECs (see [Supplementary file 2](#supp2){ref-type="supplementary-material"}). (**D--G'**) Targeting Hey in ECs resulted in increased expression of Hey-putative direct target RecQ4 protein in small cells that are LamC^(-)^ Delta^(+)^ (compare D to E, and F to G). (**G'**) Quantification of polyploid cells (PPCs) that co-express Delta and RecQ4 in control and midguts where Hey is targeted in ECs. Arrows indicate cells shown in insets. Scale bar is 10 μm. (**H**) Venn diagram comparison of genes regulated by Hey in progenitors (**P**) and ECs. Gene loci also bound by Hey, as identified by DamID, are indicated by a gray rectangle. Vertical bars indicate the percent of genes whose expression is repressed (green) or activated (red) upon Hey knockdown (**I**) A non-canonical HES binding site is enriched in Hey bound loci. (**J--M**) Single gene examples of genomic loci bound by Hey using DamID. Binding profile of Hey over the genomic regions encoding for *delta* (**J**), *Pdm1* (**K**), *LamC* (**L**) *LamDm0* (**M**). Single peaks and regions are shown in orange and blue, respectively. The mean signal was smoothed +whiskers. Predicted enhancers were identified using modENCODE are depicted as orange lines, and coding regions are shown as black arrowed lines. modencode.org/publications/integrative fly ([@bib33]); GSE22069 ([@bib31]),\_([@bib80]).\
10.7554/eLife.44745.018Figure 3---source data 1.Quantification data related to [Figure 3G\'](#fig3){ref-type="fig"} - number of PPC Dl(+) RecQ4(+).](elife-44745-fig3){#fig3}

Concomitantly, loss of Hey in ECs resulted in ectopic expression of pathways associated with nuclear and DNA-related processes (such as TFs, DNA replication/repair, ncRNAs, and nuclear organization ([Figure 3C](#fig3){ref-type="fig"}, [Figure 3---figure supplement 3H](#fig3s3){ref-type="fig"}, [Supplementary file 2](#supp2){ref-type="supplementary-material"}). The origin of these upregulated DEGs likely reflects PPC\*\* and PPC\* expression signatures, as well as an increase in rapidly dividing progenitors, as well as other cell populations that were newly present in the targeted gut ([Figure 3D--G'](#fig3){ref-type="fig"}).

We validated these results for a subset of genes at the protein level. For example, Delta, *maelstrom (*[Figure 3---figure supplement 1I--J](#fig3s1){ref-type="fig"}), and *γ-tubulin* ([Figure 3---figure supplement 1K--L](#fig3s1){ref-type="fig"}), which are normally repressed by Hey, were ectopically upregulated in polyploid cells ([Figure 1G, G', I and I'](#fig1){ref-type="fig"}, [Figure 3---figure supplement 1I--P](#fig3s1){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}). Bona fide EC-specific genes *pdm1, odd-skipped, snakeskin, MESH, fasciclin,* which require Hey for their expression, exhibited reduced expression (see examples in [Figures 1F,H](#fig1){ref-type="fig"} and [2G,G'](#fig2){ref-type="fig"} (Pdm1); 2H, H', [Figure 1---figure supplement 1D,D'](#fig1s1){ref-type="fig"}, [Figure 3---figure supplement 1M,N](#fig3s1){ref-type="fig"} (Odd); 2I, I' (SSK); 6E, F (MESH); Figure 6---figure supplement 1 (Fas, SSK, Dlg); [Supplementary file 1](#supp1){ref-type="supplementary-material"}). These gene signatures are consistent with other studies that depict cell-specific gene profiles of midgut cells and regulators ([Supplementary file 6](#supp6){ref-type="supplementary-material"}; [@bib56]); <https://flygut.epfl.ch/expressions>). Moreover, loss of Hey resulted in the ectopic expression of progenitors and non-gut-related programs such as neurogenesis (12 genes, [Supplementary file 2](#supp2){ref-type="supplementary-material"}), which is exemplified by the ectopic expression of the neuronal marker 22C10 in PPCs\* (PPCs ^GFP(-)\ RFP(-)^) cells ([Figure 2M,N](#fig2){ref-type="fig"}; [Figure 3---figure supplement 1O,P](#fig3s1){ref-type="fig"}). Targeting Hey in ECs also effected the cellular composition of the gut and resulted in the emergence of new cell populations ([Figure 3D--G'](#fig3){ref-type="fig"}). For example, RecQ4, a Hey-regulated target gene ([Supplementary file 1](#supp1){ref-type="supplementary-material"}), is a DNA helicase that is co-expressed with LamC in fully differentiated ECs but not in ISCs ([Figure 3D and F](#fig3){ref-type="fig"}). Following Hey knockdown in ECs, we observed small cells expressing only RecQ4, without LamC but with Delta (RecQ4^(+)^, Delta^(+)^, LamC^(-)^). We also observed that 17% of PPCs are RecQ4^(+)^, Delta^(+)^ ([Figure 3E and G,G'](#fig3){ref-type="fig"}). These population of cells were not observed in control guts.

In parallel, we identified a group of Hey-regulated genes in progenitors (predominantly EBs) using an enriched affinity purification protocol. To identify Hey-regulated genes in progenitors, we expressed the CD8-GFP molecule on the surface of progenitors using the Hey-Gal4 (that is expressed predominantly EBs), along with control (UAS-GFP) or UAS-Hey RNAi (see detailed in Materials and methods). This surface labeling enabled us to affinity purify progenitors via CD8 magnetic beads and to compare the gene expression signature of control or Hey RNAi purified progenitors. We observed that three hundred and forty-five genes exhibited Hey-dependent regulation and were involved in progenitor maturation and EB identity ([Supplementary file 1](#supp1){ref-type="supplementary-material"}; [Supplementary file 2](#supp2){ref-type="supplementary-material"}). We found that the expression signature of Hey in ECs is unique and overlaps only minimally with Hey-regulated genes in progenitors with only 10% (40) shared genes, suggesting cell-specific functions of Hey ([Figure 3H](#fig3){ref-type="fig"}). The transcriptional analysis of Hey-regulated genes in progenitors is consistent with our genetic experiments: upon cell-specific RNAi reduction of Hey in either ISC, EB, or both, the number of ECs declined and many progenitor cells were unable to maintain proper identity ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). In addition, *hey*-deficient clones generated by MARCM did not survive and were likely rapidly outcompeted ([Figure 3---figure supplement 3A--D](#fig3s3){ref-type="fig"}). In accordance, forced expression of Hey in progenitor cells resulted in the rapid differentiation of progenitors to PPCs, and ectopic endoreplication of *esg*::GFP^+^ progenitors together with reduced Delta expression (but not Pdm1 expression) ([Figure 3---figure supplement 3E,F](#fig3s3){ref-type="fig"} and not shown).

To identify putative direct transcriptional effects of Hey, we mapped the genomic loci bound by Hey using DamID chromatin profiling ([Figure 3H--M](#fig3){ref-type="fig"}, [Figure 3---figure supplement 4A--C](#fig3s4){ref-type="fig"}; [Supplementary file 3](#supp3){ref-type="supplementary-material"}; [@bib36]; [@bib73]; [@bib79]). We were unable to generate Dam-Hey transgenic lines, preventing the mapping of Hey-DamID in gut cells. Instead, we performed DamID mapping in *Drosophila* Kc167c cells. Overall, we identified \~4000 Hey-associated genomic regions ([Supplementary file 3](#supp3){ref-type="supplementary-material"}). Hey-bound loci were enriched for non-canonical HES/Hey-related binding motif, which was also shown to be a preferred binding motif for mammalian Hey proteins (CANNTG, e = 5.4×10^−4^, [Figure 3I](#fig3){ref-type="fig"}; [@bib44]). We found that Hey bound the genomic regions of 32% (127/370) and 35% (127/345) of Hey-regulated genes in ECs and progenitors, respectively ([Figure 3H](#fig3){ref-type="fig"}). By comparing Hey-DamID with Hey-regulated genes, we identified distinct sets of putative Hey targets in progenitors and ECs with only 10 shared targets, further supporting cell-specific functions of Hey. Moreover, in each group, about \~70% of Hey-regulated genes that were bound by Hey in DamID required Hey for their expression. ([Figure 3H](#fig3){ref-type="fig"}, [Supplementary files 1](#supp1){ref-type="supplementary-material"},[2](#supp3){ref-type="supplementary-material"},[4](#supp4){ref-type="supplementary-material"}). For example, Hey binding was observed in predicted enhancer regions of *delta, pdm1, lamC, lamDm0, broad, γ-tubulin,* and *pointed,* th only residual expression in ISCs a their expression in ECs was shown to be regulated by Hey ([Figure 3J--M](#fig3){ref-type="fig"}, [Figure 3---figure supplement 4A--C](#fig3s4){ref-type="fig"}). A detailed analysis of DamID results will be presented elsewhere.

Hey regulates chromatin and nuclear organization of ECs {#s2-4}
-------------------------------------------------------

At the chromatin level, Hey binding correlated with genomic regions enriched for histone tail modifications associated with gene activation, such as the dual histone marks H3K4me1^+^/H3K27ac^+^, H3K4me2, H3K4me3, H4K16ac ([Figure 4A](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1A--E](#fig4s1){ref-type="fig"}). In contrast, Hey binding was not correlated with histone marks associated with poised enhancers (H3K4me1^+^/H3K27ac^-^), or silenced chromatin ([Figure 4A](#fig4){ref-type="fig"}; [Figure 4---figure supplement 1F--H](#fig4s1){ref-type="fig"}; modENCODE, 2010; [@bib28], and reviewed in [@bib87]). Indeed, we found that Hey regulates histone tail modifications associated with gene activation in vivo. In this set of experiments, we used the regional 103--555 Gal4 driver, which is active only in enterocytes within a sub-gut region, while neighboring ECs outside the targeted region served as control ([Figure 4B](#fig4){ref-type="fig"} [Figure 4---figure supplement 2A--E](#fig4s2){ref-type="fig"}). Regional downregulation of Hey reduced the H3K27ac signal only in ECs located within the targeted zone ([Figure 4C and C'](#fig4){ref-type="fig"} and quantified in [Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). Similar results were also observed upon inactivating Hey using the general EC MyoIA^ts^Gal4 system ([Figure 4---figure supplement 3H--K](#fig4s3){ref-type="fig"}). Furthermore, H3K27ac protein levels were reduced in *Drosophila* Schneider S2R cells transduced with Hey RNAi ([Figure 4H](#fig4){ref-type="fig"}), suggesting that Hey may be required to maintain H3K27ac. Alongside these observations in ECs, Hey represses the expression of the stem cell *M5-4* enhancer sequence, which promotes the expression of the stem cell-related *esg* TF ([@bib34]). We observed that, in control guts, the *M5-4* enhancer drives Lac-Z expression only in progenitor cells but not in ECs or EEs ([Figure 4D](#fig4){ref-type="fig"}, [Figure 4---figure supplement 3A--D](#fig4s3){ref-type="fig"}). Following loss of Hey in ECs, however, the *M5-4* enhancer drove robust lac-Z expression not only in stem cells but also in polyploid cells and specifically in PPC\*\* ([Figure 4E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 3E,F and G](#fig4s3){ref-type="fig"}-TRACE analysis 2K, 2L). This suggests that under physiological conditions and in ECs, Hey represses the activity of a progenitor-specific enhancer.

![Hey regulates chromatin and large-scale nuclear organization.\
(**A**) End analysis of Hey DamID signal to H3K4me1-enriched regions containing H3K27Ac (red). (**B**) Schematic diagram of regional EC-targeting system. GFP marks ECs where RNAi is active (targeted region). (**C, C'**) Confocal images of regional targeting of Hey in ECs. H3K27Ac is shown in red, targeted ECs are GFP-positive, and the targeted region is below the dashed white line. (**D--G**) RNAi-mediated targeting of Hey using *Myo1A*-GAL4^ts^ for 48 hr resulted in increased and ectopic expression of the *esg* gene stem cell enhancer (*M5-4*::LacZ) (**D, E**), and in an increase in chromatin accessibility (**F, G**) as measured by *M-*SSL-I assay, 5mC is shown in red (see text for details). DAPI (blue) marks DNA, and scale bar is 10 μm. (**H**) Western blot analyses of the indicated proteins in extract derived from S2R + cells that were transfected with GFP RNAi or Hey RNAi. Actin serves as loading control. (**I--Z**). Single cell images of RNAi-mediated reduction of Hey, but not control, in ECs resulted in changes in the expression and distribution of the indicated proteins associated with intranuclear organelles and chromatin/nuclear domains; Representative images of G-TRACE analysis are shown in (**K', L', S' T', U' V', W', X'**). DAPI marks DNA. (**AA-DD**) expression of nuclear lamins in midgut cells (AA) ISCs are Delta positive (red) and express LamDm0 (purple). EBs are marked by *Hey-*Gal4 \>GFP (green). (BB, CC) Immunostaining of LamC (red) and the indicated cell-specific transgenes (green), arrows indicate cells in insets: (BB) ISCs are marked by Delta-GAL4 \>UAS GFP; (CC) EBs are marked by Su(H)-GAL4 \> UAS GFP. (DD) Distribution of lamins during ISC differentiation to ECs.](elife-44745-fig4){#fig4}

We hypothesized that the ectopic expression of a stem-cell enhancer in PPCs\*\* as well as PPCs^\*^ may be due to permissive changes in chromatin organization. We therefore investigated whether loss of Hey in ECs results in a global change in chromatin conformation using an M. SssI methylation-based chromatin accessibility assay ([Figure 4F,G](#fig4){ref-type="fig"}; [@bib79]). In brief, the M. SssI enzyme efficiently methylates CpG dinucleotides in vitro depending on chromatin accessibility. This methylation is endogenously minimal in differentiated somatic *Drosophila* cells. The methylated dinucleotides are subsequently detected using 5mCmAb ([@bib5]). Only minimal 5mC methylation was detected in control gut ECs (9%, n = 206), but upon Hey knockdown, a significant increase in 5mC was detected in PPCs using immunofluorescence with the 5mC antibody likely (22% n = 406; p\<0.001) ([Figure 4F,G](#fig4){ref-type="fig"} and quantitated in [Figure 4---figure supplement 3G](#fig4s3){ref-type="fig"}).

While Hey proteins are sequence-specific transcription factors that regulate the expression of distinct genes, these observations led us to test whether loss of Hey affected global organization of differentiated EC nuclei. We therefore examined the expression and localization of proteins that are associated with chromatin regions and non-chromatin subnuclear organelles ([Figure 4I--Z](#fig4){ref-type="fig"} and qauntified in [Figure 4---figure supplement 3L](#fig4s3){ref-type="fig"}). RNAi-mediated depletion of Hey resulted in impaired expression and distribution of heterochromatin protein 1 c (HP1c), which was no longer localized to the chromocenter ([Figure 4I,J](#fig4){ref-type="fig"}). It also resulted in an increased distribution of Nop60B and Coilin, which mark the nucleolus and Cajal bodies, respectively ([Figure 4K--N](#fig4){ref-type="fig"}). We also observed impairment in the nuclear localization of LSM11 that is associated with the histone locus bodies (HLBs) ([Figure 4O,P](#fig4){ref-type="fig"}). At the nuclear periphery, localization of Mtor, a nuclear envelope component, was distorted. Alongside we observed changes in the expression of nuclear lamins ([Figure 4Q--V](#fig4){ref-type="fig"}). We observed reduced expression of Lamin C and increased expression of LamDm0. We also observed increased expression of the LamDm0 binding protein, Otefin, as well as its redistribution to the nuclear periphery ([Figure 4W--X' and H](#fig4){ref-type="fig"}, and qauntified in [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). In contrast, the immunofluorescence signal of the co-repressor dSin3A, which functions in HES-mediated repression, was identical in both Hey-RNAi- and control-targeted gut ([Figure 4Y,Z](#fig4){ref-type="fig"}, [Figure 1---figure supplement 3K,L](#fig1s3){ref-type="fig"}). Thus, loss of Hey results in global changes in the organization of the EC nucleus.

Hey regulates the expression of nuclear lamins {#s2-5}
----------------------------------------------

Maintaining cell identity requires the establishment of high-order nuclear organization involving nuclear lamins ([@bib55]; [@bib42]). Our binding and expression data predicted that Hey partially shapes the organization of the differentiated EC nucleus by regulating lamin expression ([Figures 3L, M](#fig3){ref-type="fig"} and [4S--V'](#fig4){ref-type="fig"}, [Supplementary files 1](#supp1){ref-type="supplementary-material"},[3](#supp3){ref-type="supplementary-material"}). We therefore further examined the regulation of nuclear lamins by Hey in ECs and the role of lamins in supervising EC identity.

Nuclear lamins are essential for establishing facultative heterochromatin and gene silencing ([@bib25]; [@bib55]; [@bib37]). They contribute, in part, to the specification of lamin-associated domain regions (LADs) characterized by low gene expression levels ([@bib38]; [@bib2]). The *D. melanogaster* genome encodes for two intermediate filament lamin genes: LaminDm0 (LamDm0), a type-B lamin, and lamin C (LamC), a type-A lamin expressed predominantly in differentiated cells.

Remarkably, the distribution of A and B type nuclear lamins is distinctive: LamDm0 is highly expressed in both ISCs and EEs, but is present in only low levels in EBs and ECs. In contrast, LamC is expressed in EBs and ECs with only residual expression in ISCs and EEs ([Figure 4AA-DD](#fig4){ref-type="fig"}, [Figure 5---figure supplement 1D,E](#fig5s1){ref-type="fig"}).

We found that Hey establishes and maintains a unique organization of lamins in ECs. Regional depletion, as well as general depletion of Hey in ECs resulted in a decline in LamC expression and in an increased LamDm0 protein levels in ECs ([Figure 5A--B'](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1A--C and F--I](#fig5s1){ref-type="fig"}). Using G-TRACE analyses, we also observed that PPCs^\*\*^ exhibits ectopic expression of LamDm0 ([Figure 5C,D](#fig5){ref-type="fig"}) and reduced levels of LamC protein ([Figure 5E,F](#fig5){ref-type="fig"}). Importantly, the changes in LamC and LamDm0 expression, as well as nuclear organization (such as the localization of Mtor), were not observed upon exposure to 5 mM paraquat, that induces rapid progenitor proliferation ([Figure 5---figure supplement 2I-P](#fig5s2){ref-type="fig"}; [@bib19]). Thus, these changes are directly related to loss of Hey supervision in ECs.

![Hey regulates the expression of nuclear lamins, which determine cell identity.\
(**A--B'**) Effects of regional Hey targeting in ECs on the expression of LamDm0 and LamC. Hey RNAi is expressed in ECs that co-express GFP and are below the dashed line. RNAi activation was for 48 hr. (**C--F**) G-TRACE analyses of LamDm0 (**C, D**) and LamC (**E, F**) in control and Hey-targeted ECs. Lamin proteins are shown in purple. Numbers in each figure indicate: (1) EC; (2) PPC\*\*; (3). PPC\*. Yellow arrows indicate PPC\*\* shown in insets. (**G--H'**) Expression of Hey (**H, H'**), but not control (**G, G'**), in progenitors cells reduces the expression of LamDm0 and Delta. (**I**) Quantification of a large midgut area in similar setting to G-H' (\*\*\*\*=P \< 0.0001). (**J--Q**) Confocal images from guts derived from the indicated transgenes and antibodies. (**J, K**) RNAi-dependent knockdown of LamC in ECs using *MyoIA-*Gal4/Gal80^ts^ results in ectopic expression of Delta (red). (**L, M**) RNAi-mediated targeting of LamDm0 in progenitor cells using *esg-*Gal4/Gal80^ts^ (along with UAS-GFP) results in ectopic Pdm1 expression in these cells (GFP^+^, red). (**N, O**) Ectopic expression of LamC in progenitor cells results in reduced Delta expression (red). White dashed squares indicate cells shown in insets. (**P, Q**) Ectopic expression in ECs of LamDm0-GFP (Q, green), but not of control, (**P**) resulted in reduced Pdm1 expression (red). (**R**) Venn diagram comparison of the indicated differentially expressed genes (DEG). \*1, p=4.03e^−72^; \*2, p=3.61e^−79^; \*3, p=1.35e^−85^ (**S**) Comparison between Hey-putative direct targets in ECs and genes regulated by ectopic expression of LamDm0-GFP in ECs. (**T--W**) Quantification biological repeat similar to the ones shown in J-Q. (**T**) PPCs expressing Delta. (**U**) Cells that are *esg::*GFP positive and that are positive for Pdm1. (**V**) Cells that are *esg::*GFP positive and are positive for Delta. (**W**) PPC positive for Pdm1 in experiments similar to the ones shown in J-Q respectively. \*\*\*\*=p \< 0.0001.\
10.7554/eLife.44745.030Figure 5---source data 1.Quantification data related to [Figure 5](#fig5){ref-type="fig"}.Quantification data related to [Figure 5I](#fig5){ref-type="fig"} number of esg-GFP positive cells Dl(+), LamDm0(+). Quantification data related to [Figure 5T](#fig5){ref-type="fig"} - number of PPC Dl(+). Quantification data related to [Figure 5U](#fig5){ref-type="fig"} - esg-GFP positive cells Pdm1(+). Quantification data related to [Figure 5V](#fig5){ref-type="fig"} - number of esg-GFP positive cells Dl(+). Quantification data related to [Figure 5W](#fig5){ref-type="fig"} - number of PPC Pdm1(+).](elife-44745-fig5){#fig5}

Moreover, forced expression of Hey in progenitor cells (esg-GPF positive cells) resulted in reduced expression of the stem cell-related lamin, LamDm0, as well as Delta ([Figure 5G--I](#fig5){ref-type="fig"}). Only 4.5% of progenitor cells co-express LamDm0 and Delta compare to 100% in control ([Figure 5I](#fig5){ref-type="fig"}). Loss of Pdm1 in ECs similarly resulted in an inability to maintain the expression of EC-specific genes like LamC and Caudal and in the upregulation of LamDm0 ([Figure 5---figure supplement 2C--H](#fig5s2){ref-type="fig"}). Unlike the case of Hey, however, RNA-mediated knockdown of Pdm1 in ECs did not result in ectopic expression of Delta in these cells ([Figure 5---figure supplement 2A,B](#fig5s2){ref-type="fig"}). Moreover, co-expression of Pdm1 along with Hey elimination in ECs did not suppress Hey phenotypes (not shown), suggesting that, in ECs, Pdm1 function is not redundant with Hey.

Nuclear lamins determine cell identity {#s2-6}
--------------------------------------

It is commonly thought that the association of nuclear lamins with the genome is inhibitory ([@bib2]; [@bib37]). We hypothesized that lamins maintain cell identity in part by inhibiting the expression of non-relevant transcriptional programs. Indeed, eliminating LamC in ECs using LamC-RNAi resulted in ectopic expression of the stem cell marker Delta on the surface of PPCs ([Figure 5J,K,T](#fig5){ref-type="fig"}). Eliminating LamDm0 from progenitor cells similarly resulted in ectopic expression of the founder EC gene Pdm1 ([Figure 5L,M,U](#fig5){ref-type="fig"}). Moreover, conditional ectopic expression of the differentiated LamC, but not of LamDm0, in progenitor cells resulted in a decline in the expression of the stem cell marker Delta ([Figure 5N,O,V](#fig5){ref-type="fig"}, and controls shown in [Figure 5---figure supplement 1N,O](#fig5s1){ref-type="fig"}). Expression of stem cell-related LamDm0 in ECs, but not of LamC, resulted in reduced expression of the EC-related transcription factors, Pdm1 and Odd-skipped ([Figure 5P,Q,W](#fig5){ref-type="fig"}; [Figure 5---figure supplement 2J--M](#fig5s2){ref-type="fig"}).

To gain a comprehensive view on the program(s) regulated by the ectopic over-expression of LamDm0 in ECs, we performed RNA-Seq analysis. Using MyoIA^ts^-GAL4, driving the expression of UAS-LamDm0 we identified 810 DEGs upon LamDm0 expression in ECs compared with control (UAS-GFP, PCA analysis shown in [Figure 5---figure supplement 4](#fig5s4){ref-type="fig"}, and see Materials and methods). We identified 155 genes (FDR \< 0.05), termed 'Group 1' (G1), that are highly expressed in ECs and whose expression was repressed by LamDm0. These genes encode for proteins that are involved in differentiated ECs physiology and metabolism ([Figure 5---figure supplement 4A,C,E](#fig5s4){ref-type="fig"}). We also identified 154 genes (FDR \< 0.05), termed 'Group2' (G2), that exhibit upregulated expression upon expression of LamDm0 and are highly expressed in progenitor cells, but not in ECs. These genes are involved in cell cycle, DNA repair, chromatin organization and transcription, RNA transport, and lateral inhibition ([Figure 5---figure supplement 4B,D](#fig5s4){ref-type="fig"}). Data comparison showed that many LamDm0 DEGs are co-regulated by Hey and are repressed by the expression of the progenitor transcription factor Escargot (Esg) in ECs ([Figure 5R](#fig5){ref-type="fig"}; [@bib56]) and in comparison to fly gut gene expression resource [Figure 3---figure supplement 3E](#fig3s3){ref-type="fig"}; <https://flygut.epfl.ch/expressions>). Moreover, 30% (36/127) of Hey putative direct targets are regulated by LamDm0 in ECs ([Figure 5S](#fig5){ref-type="fig"}). Thus, loss of EC identity stems from active reconfiguration of EC nuclei, as a result of the acute loss of Hey or aberrant lamin expression. [](#fig5s1){ref-type="fig"}

Perturbation of hey or lamin expression in ECs results in impaired gut homeostasis and reduced organismal survival {#s2-7}
------------------------------------------------------------------------------------------------------------------

RNA-mediated knockdown of Hey in ECs not only impaired EC identity but also affected the entire epithelial tissue and gut homeostasis activating stress/regeneration pathways and impaired tissue integrity ([Figure 1K--N](#fig1){ref-type="fig"}, and [Figure 6](#fig6){ref-type="fig"}). EC-specific Hey knockdown disrupted the organization of the epithelial tissue, as shown by the decline in expression of EC-specific cell adhesion proteins MESH, Snakeskin (SSK), Fasciclin (FasIII), and the septate junction protein Dlg ([Figures 6A,B](#fig6){ref-type="fig"} and [2I,I'](#fig2){ref-type="fig"}; [Figure 6---figure supplement 1A--F](#fig6s1){ref-type="fig"}; [@bib49]; [@bib99]; [@bib56]). Concomitantly, we observed the ectopic expression of Armadillo protein (*Drosophila* β-catenin) on the surface of polyploid cells ([Figure 6C,D](#fig6){ref-type="fig"}).

![Perturbation in the expression of identity supervisors impairs gut homeostasis and gut integrity and reduces survival.\
(**A--N**) Confocal images of adult *Drosophila* midgut epithelium derived from the indicated transgenes. Activation of UAS-transgenic lines was for 48 hr. DAPI marks DNA, and scale bar is 10 μm. (**A--D**) Loss of Hey in ECs results in reduced expression of the tight junction protein MESH at cell boundaries (**A, B**), and ectopic Armadillo protein levels (Arm, red) on the surface of large polyploid cells (**C, D**). Insets in A-D are smaller magnifications of the epithelial tissue. (**E--J**) Expression of MESH (**E--G**) or Arm (**H--J**) in midguts derived from the indicated transgenic lines expressed in ECs under the control of MyoIA*-*Gal4/Gal80^ts^. (**K--L**). Expression of STAT reporter transgenic lines in control (**K**), or UAS-LamC-RNAi (**L**), expressed in ECs using MyoIA*-*Gal4/Gal80^ts^. (**M--O**) Targeting Hey results in an increased number of small cells that are positive for both pH3 and Delta. (**O**) Quantification of the number of phospho-H3 cell positive in 31 midguts (15 control and 16 of Hey-i) in similar experimental setting to the ones shown in M and N. (**P, Q**) Targeting Hey in ECs results in leakage of blue-colored food into the abdomen, where 22% of Hey-RNAi flies show loss of gut integrity versus 0% in control flies (n = 94, p\<0.001). (**R**) Survival analyses of flies expressing the indicated transgenes in ECs under the control of MyoIA*-*Gal4/Gal80^ts^ (n = 180, \*\*\*\*p\<0.0001).\
10.7554/eLife.44745.033Figure 6---source data 1.Quantification data related to [Figure 6O](#fig6){ref-type="fig"} - total number of phospho H3(+) cells per ROI.](elife-44745-fig6){#fig6}

Perturbation in Lamin expression also effected gut integrity and homeostasis. Expression of LamDm0 in ECs repressed the expression of EC-specific genes, as seen for example in the reduced expression of adhesion protein MESH as opposed to the RNAi-dependent elimination of LamC in ECs, which had no effect on MESH expression ([Figure 6E--G](#fig6){ref-type="fig"}). Likewise, Arm, which is expressed only on the surface of progenitor cells, was ectopically expressed on the surface of PPCs upon LamC elimination, but not upon LamDm0 over-expression in ECs ([Figure 6H--J](#fig6){ref-type="fig"}). Eliminating LamC similarly resulted in ectopic expression of STAT-GFP reporter in polyploid cells ([Figure 6K--L](#fig6){ref-type="fig"}). Taken together, we conclude that lamins determine cell identity and have non-overlapping cell-specific repressive functions. The continued expression of LamC in ECs is required in order to prevent the expression of progenitor genes but not of differentiated EC genes.

Upon targeting Hey or LamC in ECs, we also observed an increase in mitosis of small cells, potentially ISCs (positive for both Delta and the mitotic marker phosphorylated histone H3) ([Figure 6M,N](#fig6){ref-type="fig"} quantified in 6O, and not shown), culminating in a loss of overall gut integrity, as exemplified by the leaking of blue-colored food from the gut lumen into the abdominal cavity ([Figure 6P,Q](#fig6){ref-type="fig"}; [@bib77]).

At the organismal level, Hey knockdown or expression of LamDm0 in ECs shortened the fly's lifespan. Only 2% of targeted adults survived past 32 days compared with 98% of control flies ([Figure 6R](#fig6){ref-type="fig"}; DT~50~23 days, n = 300, p\<0.0001). Thus, continued Hey expression in ECs and the precise expression of lamins are essential for proper gut homeostasis, tissue integrity, and adult survival.

Aging impairs EC identity, which is preserved by continued Hey expression in aged ECs {#s2-8}
-------------------------------------------------------------------------------------

Perturbation in nuclear organization is a hallmark of aged cells and tissues. In the aging *Drosophila* immune system, a decline in the type-B lamin, LamDm0, in fat body cells induces systemic inflammation including in the mid-gut ([@bib20]). Aging also resulted in loss of intestinal compartmentalization, and microbiota-dysbiosis, all leading to reduces life-span ([@bib58]). During aging, EC physiology, midgut integrity, and homeostasis are compromised (reviewed in [@bib66]). Indeed, we noticed that Hey protein levels in ECs decline with age ([Figure 7A,B](#fig7){ref-type="fig"}). Moreover, the phenotypes resulting from acute conditional knockdown of Hey in young flies (2--4 days old) are highly similar to the phenotypes observed in wildtype guts derived from aged flies (3--4 weeks old). As seen in [Figure 7C--J](#fig7){ref-type="fig"}, aging ECs exhibit a reduction in the MyoIA-GFP signal, a decline in Pdm1 and LamC expression, along with ectopic expression of Delta and LamDm0 and overall reduced gut integrity ([Figure 7C, E, G, I and K](#fig7){ref-type="fig"}). Indeed, continued expression of Hey in aged ECs using MyoIA^ts^-Gal4 prevented the ectopic expression of Delta and LamDm0 ([Figure 7D and J](#fig7){ref-type="fig"}), restored the expression of Pdm1 ([Figure 7E and F](#fig7){ref-type="fig"}), of LamC ([Figure 7G and H](#fig7){ref-type="fig"}), and of overall EC morphology, compared with control. Finally, expression of Hey prevented loss of gut integrity as revealed by the 'smurf' assay ([Figure 7K and L](#fig7){ref-type="fig"}). Thus, by supervising EC identity, Hey attenuates epithelial aging and safeguards gut integrity.

![Hey protein level declines in aged ECs and its over-expression suppresses aging phenotypes.\
(**A, B**) Confocal images of Hey protein (red) in young (**A**) and aged (**B**) adult midgut epithelium. DAPI marks DNA, and scale bar is 10 μm. (**C--J**) Confocal images with the indicated antibodies of ECs expressing either UAS-LacZ (control, (**C, E, G, I**), or UAS-Hey (**D, F, H, J**) transgenes using the MyoIA^ts^-Gal4. White arrow indicates cells shown in insets. (**K, L**) Aged ECs exhibit leakage of blue-colored food into the abdomen, which is prevented by expression of UAS-Hey (**L**), but not control (**K**) where only 7% of aged flies expressing Hey show loss of gut integrity versus 28% in control aged flies (n = 52, and 30 respectively, p\<0.05). (**M**) A model for regulation of cell identity by Hey and nuclear lamins; NRG, non-relevant genes (see text for details).](elife-44745-fig7){#fig7}

Discussion {#s3}
==========

We identified Hey, but not other HES transcription factors, as a critical supervisor of EC identity and suggest the following working model ([Figure 7M](#fig7){ref-type="fig"}): Hey regulates EC identity in part by establishing and sustaining a transcriptional switch in the expression of nuclear lamins. In ISCs, the dominant lamin is LamDm0, which prevents the expression of differentiated genes. During differentiation and in differentiated ECs, Hey represses the expression of LamDm0, enabling the expression of genes required for EC physiology and function. In addition, Hey promotes the expression of EC gene signatures, including Pdm1 and LamC, the latter inhibits the expression of stem cell- and non-gut-related genes in ECs. Hey loss during aging or upon its acute genetic ablation in young midguts, results in ectopic expression of LamDm0 and subsequently silencing of EC programs including critical EC TFs (e.g. Pdm1 and Odd-skipped). Concomitantly, Hey loss in ECs causes a decline in LamC and, as a consequence, ectopic expression of stem cell- and non-gut-related genes that are normally repressed by LamC in ECs.

Transcriptional regulation of EC identity by Hey {#s3-1}
------------------------------------------------

Although HES**/**Hey proteins are well-known repressors ([@bib44]), our study suggests that in ECs, Hey has both repressive and activating functions. This dual transcriptional activity of Hey in *Drosophila* is similar to its classification in mammalian transcription factors ([@bib89]) and is important for maintaining EC identity. In ECs, Hey represses the expression of numerous progenitor-related genes whose expression depends on the progenitor transcription factor Esg, such as *Delta*, *snail*, *piwi*, and the ISC-related lamin, LamDm0 ([@bib27]; [@bib56]). Hey concomitantly drives the expression of key EC founder genes (e.g. *pdm1, odd)* and EC-differentiated genes including LamC. Of specific interest is the regulation of the EC founder *Pdm1* ([@bib56]). We found that *pdm1* mRNA levels increase during progenitor-to-EC differentiation and that Hey safeguards *pdm1* expression through two mechanisms. First, Hey binds to a predicted enhancer within the *pdm1* gene, inducing and maintaining Pdm1 expression in ECs. Second, Hey-dependent repression of *lamDm0* indirectly ensures continuous *pdm1* expression. Collectively these data place Hey upstream of *pdm*1 and nuclear lamins. Pdm1 expression in Hey-targeted ECs was not, however, sufficient to restore EC identity or prevent the expression of a stem cell gene like *Delta*, suggesting that Hey functions are not compensated by Pdm1 expression alone. Yet, our observation that both Hey and Pdm1 regulate genes like *LamDm0* warrants an investigation of the nature of the interaction between the two proteins in ECs.

Hey regulates chromatin and nuclear organization {#s3-2}
------------------------------------------------

While Hey is a sequence-specific transcription factor, Hey loss affects global nuclear organization, resulting in increased chromatin accessibility as well as changes in the expression and distribution of protein that are distinctive for intranuclear organelles and nuclear domains.

Interestingly, the phenotypes associated with loss of Hey in ECs are reminiscent of the phenotype observed upon loss of Wiskott-Aldrich syndrome protein (WASP), which binds directly to LamDm0 ([@bib95]). This may indicate that large-scale nuclear organization involves a general network that includes nuclear lamins. One possibility is that this regulation may also be dependent on enhancer-associated RNAs (eRNAs), or other non-coding RNA molecules ([@bib3]; [@bib14]). Future challenges are therefore to identify the molecular mechanisms that determine the differential effect of Hey on enhancers within the same cell, and the exact mechanisms by which Hey maintains subnuclear organization.

Recent work on reprogramming and differentiation distinguished between transcription factors that possess genome-shaping abilities (pioneer factors) and terminal transcription factors, which together shape the transcription network required to establish cell-specific states ([@bib48]; [@bib68]). We suggest that Hey is likely part of a new class of factors characterized by dual transcriptional activity with profound impact on chromatin and nuclear organization, and that it is situated below pioneer factors but upstream to terminal factors (e.g. Pdm1).

Nuclear lamins determine EC identity {#s3-3}
------------------------------------

A key aspect in maintaining large-scale nuclear organization and cell identity is mediated by nuclear lamins. In general, A-type and B-type lamins are co-expressed in many tissues within the same cell, yet form separate filament networks. In the midgut, however, while ISCs and EEs predominantly express the B-type lamin LamDm0, EBs and ECs express the A-type lamin LamC, likely defining a unique nuclear organization in each cell type. Interestingly, a sequential role of lamins in the establishment of facultative heterochromatin was reported in vertebrates. During the development of the mouse retina, early expression of Lamin-B receptor (LBR) is replaced by LamA during later stages of neuronal (rods) differentiation and, accordingly, LBR and LamA reciprocally regulate the expression of muscle-specific genes during myoblast development ([@bib88]).

Our study established that in each cell type, the dominant lamin is required in order to inhibit the expression of non-relevant programs. In EBs and differentiated ECs, LamC mediates silencing of non-EC genes. This is likely a conserved role for A/C-type lamins, as human LamA inhibits the transcription of non-adipocyte programs in differentiated adipocytes by binding in the vicinity of TSS ([@bib63]). Indeed, loss of LamC in ECs resulted in ectopic expression of Delta in PPCs^\*^ as well PPCs\*\*, exemplifying its role in repressing progenitors-related genes. Over-expression of LamC in Hey-targeted ECs was not, however, sufficient to repress ectopic Delta expression (data not shown), suggesting that the repressive activity of LamC may require the presence of Hey or a Hey-regulated protein(s) on these gene regions. Furthermore, silencing of stem cell-related genes in EC likely requires other proteins that may likely be polycomb group proteins (PcG), which are involved in anchoring chromatin to the nuclear lamina and in the generation of facultative heterochromatin ([@bib18]; [@bib37]; [@bib35]). As our manuscript was under review Petrovsky and Groβhans also characterized the expression of nuclear lamins in the midgut ([@bib76]). Similar to our observations they reported that LamDm0 and Otefin are enriched in progenitor cells. They also reported the expression of LamC in progenitors cells. Our work using ISC and EB specific markers further established that in progenitors high levels of LamC are present in EBs and only minimal amount is expressed in ISCs.

Cell-specific roles for Hey, gut homeostasis, and the impact of Hey loss during aging {#s3-4}
-------------------------------------------------------------------------------------

Hey is highly expressed in EBs where it is required for establishing EB identity and promoting Notch-dependent progenitor differentiation to ECs, similar to other HES proteins ([@bib72]; [@bib1]; [@bib75]). Notch activity is not, however, detected in ECs under normal physiological conditions. The observed Notch-reporter activity in PPCs upon Hey targeting in ECs, may reflect stress-increased ISC proliferation and Notch activation in enlarged progenitors. Alternatively, this ectopic activity may suggest that Hey limits Notch activity in ECs. Moreover, targeting *Notch* or *Su(H)* in ECs had no detectable phenotype. The function of Hey in ECs resembles the Notch-independent function of Hey1, that is maintaining pillar cell fate in the organ of Corti and in endothelial cells ([@bib26]; [@bib98]). Furthermore, while Hey is required for EC and EB identity, it is not required in order to maintain EE identity. Unlike ECs, EEs express predominantly LamDm0 and only minimally express LamC. Thus, the differentiated identity of EEs is independent of Hey and is likely maintained by other mechanisms.

The phenotypic changes following Hey knockdown are rapid, last for days, and are only partially reversible. In addition, regional targeting experiments showed that the response to targeting Hey in ECs is observed on progenitors adjacent to, but outside of the targeted region. This non-autonomous progenitor response likely involves diffusible factors secreted from PPCs^\*\*^ or other gut cells by ligands that induce ISC self-renewal such as unpaired (UPD1, UPD2). Indeed, upon Hey or LamC loss in ECs we observed enhanced activity of a JAK-STAT pathway reporter in progenitor cells as well as in polyploid cells. The regenerative process may similarly involve additional pathways that regulate stem cell regeneration ([@bib8]; [@bib21]; [@bib32]). In the absence of Hey, this regenerative response results in abnormal differentiation of progenitors (PPC\*). Mis-differentiation was also observed during direct mammalian cell reprogramming, where reprogrammed cells were incapable of fully differentiating and expressed gene signature remnants of previous fates ([@bib17]).

Our study and other reports suggest that differentiated cells have an inherent ability to reactivate de-differentiation, trans-determination, and in some cases, trans-differentiation programs. This propensity, which appears to be a shared property of cells with rapid turnovers, may have resulted from a lack of evolutionary pressure on these cells, or alternatively developed as an advantageous coping mechanism under challenging physiological conditions (e.g. stem cell exhaustion, infection). It was recently shown that under severe stress conditions, polyploid enterocytes evolve into functional stem cells in a process termed amitosis ([@bib62]).

Cell identity, aging, and pathological plasticity {#s3-5}
-------------------------------------------------

Loss of identity is a hallmark of aging, and rejuvenating of aged organisms, tissues and cells is a long-standing challenge. The mechanisms involved in regulating the differentiated identity are relevant for premature aging syndromes and aging-related diseases. iPS therapies are currently at the heart of rejuvenation strategies for aged tissues. For example, general, conditional, and transient expression of Oct4, Sox2, Klf4, and c-Myc (OSKM) suppressed cellular and physiological hallmarks of aging and prolonged lifespan in a mouse model of HSPG progeria and premature aging syndrome ([@bib71]).

Along this line, our study highlights the importance of identity guardians acting within the differentiated cell and preventing aging. We found that changes in aged ECs and in gut tissue are in part preventable and reversible. Thus, the development of strategies supporting the expression and maintaining the functionality of identity supervisors together with gene delivery systems may result in tissue rejuvenation that protects the integrity and physiological properties of both individual cells and the entire tissue.

During *Drosophila* and vertebrate aging, or under various stress conditions, differentiated cells in the gut, pancreas, and tracheal epithelium behave similarly ([@bib9]; [@bib92]), reflecting a general principle. This loss of identity, however, is intimately associated with pathological plasticity, which is highly relevant to a host of maladies including cancer. Thus, at least in some contexts, supervisors of identity such as Hey establish a barrier to tumorigenesis by regulating the expression of nuclear lamins in the differentiated nucleus. Indeed, mutations in human lamins and lamin-binding proteins are associated with heritable diseases and premature aging syndromes ([@bib7]; reviewed in [@bib16]). One well-studied case is that of human LamC ortholog, LamA, which is mutated in Progeria, a disease associated with premature aging and loss of physiological properties of differentiated cells and tissues ([@bib43]). However, further studies are needed in order to link loss of identity and premature aging in progeria models and patients, to the consequences of physiological aging. Therefore, the identification of conserved mechanisms underlying the regulation of identity networks in model organisms such as *Drosophila* has broad implications for addressing pathological conditions in humans, and specifically age-related diseases.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\                    Designation                                                                                Source or\             Identifiers            Additional\
  Or resource                                                                                                                           reference                                     information
  ------------------------------------------ ------------------------------------------------------------------------------------------ ---------------------- ---------------------- ---------------
  Genetic reagent (*D. melanogaster)*        w*^-^*, *Hey*-Gal4, UAS-CD8-GFP/FM7;+;+                                                    Orian lab                                     

  Genetic\                                   pBac{WH}Hey*^f06656^*                                                                      Bloomington            \#18997                
  reagent (*D. melanogaster*)                                                                                                                                                         

  Genetic reagent (*D. melanogaster*)        P{neoFRT}42D pwn1 P{Car20y}44B/CyO                                                         Bloomington            \#5260                 

  Genetic reagent (*D. melanogaster*)        yw, hs-flp*^122^, Tub-Gal4,Uas-*\                                                          Edgar Bruce lab                               
                                             *GFP, FRT42D Tub-Gal80/Cyo*                                                                                                              

  Genetic\                                   y, w^-^, hs-flp^122^, *Tub-Gal4*, *UAS GFP*/+; FRT42D\                                     Orian lab                                     
  reagent (*D. melanogaster*)                *Tub-Gal80*/FRT42D Hey*^f06656^*                                                                                                         

  Genetic\                                   y, w-, hs-Flp122, Tub-Gal4, UAS GFP/+; FRT42D                                              Orian lab                                     
  reagent\                                                                                                                                                                            
  (*D. melanogaster*)                                                                                                                                                                 

  Genetic reagent\                           w; *MyoIA-*Gal4; *tub*-Gal80ts, UAS-GFP                                                    Edgar Bruce lab                               
  (*D. melanogaster*)                                                                                                                                                                 

  Genetic reagent\                           *w*; esg-Gal4, *tub-*Gal80ts UAS-GFP                                                       Edgar Bruce lab                               
  (*D. melanogaster*)                                                                                                                                                                 

  Genetic reagent (*D. melanogaster*)        w; Prospero-Gal4                                                                           Edgar Bruce lab                               

  Genetic reagent (*D. melanogaster*)        w; *Dl-*Gal4/TM6, Tb                                                                       Sarah Bray lab                                

  Genetic reagent (*D. melanogaster*)        Su(H)-Gal4                                                                                 Sarah Bray lab                                

  Genetic reagent\                           Notch-reporter 3.37-gh-LacZ                                                                Sarah Bray lab                                
  (*D. melanogaster*)                                                                                                                                                                 

  Genetic reagent (*D. melanogaster*)        10X-STAT::GFP                                                                              Lilach Gilboa lab                             

  Genetic reagent (*D. melanogaster*)        M5-4::LacZ                                                                                 Erika Matunis lab                             

  Genetic reagent\                           UAS-LamC                                                                                   Lori Walworth lab                             
  (*D. melanogaster)*                                                                                                                                                                 

  Genetic reagent (*D. melanogaster*)        y\* w\*; P{w + mW.hs=GawB}NP0203/CyO,P{w-=UAS lacZ.UW14}UW14                               DGRC                   \#103555               

  Genetic reagent (*D. melanogaster*)        UAS-Hey-RNAi                                                                               VDRC                   \#30562GD              

  Genetic\                                   UAS-Hey-RNAi                                                                               VDRC                   \#103570KK             
  reagent (*D. melanogaster*)                                                                                                                                                         

  Genetic reagent (*D. melanogaster*)        UAS-Hey-RNAi                                                                               Bloomington            \#31898                

  Genetic reagent (*D. melanogaster*)        UAS-Hey-RNAi                                                                               Bloomington            \#41650                

  Genetic reagent\                           UAS-Hey-RNAi                                                                               NIG-FLY                11194 R-1              
  (*D. melanogaster*)                                                                                                                                                                 

  Genetic reagent\                           UAS-Hey-RNAi                                                                               NIG-FLY                11194 R-3              
  (*D. melanogaster*)                                                                                                                                                                 

  Genetic reagent (*D. melanogaster*)        UAS-LacZ                                                                                   Bloomington            \#1776                 

  Genetic reagent (*D. melanogaster*)        UAS-Hairy RNAi                                                                             Bloomington            \#27738                

  Genetic reagent (*D. melanogaster*)        UAS-Her RNAi                                                                               Bloomington            \#27654                

  Genetic reagent (*D. melanogaster*)        UAS-HLHm7 RNAi                                                                             Bloomington            \#35703, \#29327       

  Genetic reagent (*D. melanogaster*)        UAS-HLHm5 RNAi                                                                             Bloomington            \# 26201               

  Genetic reagent (*D. melanogaster*)        UAS-CtBP RNAi                                                                              Bloomington            \#32889                

  Genetic reagent\                           UAS-Sir2 RNAi                                                                              Bloomington            \#32481                
  (*D. melanogaster*)                                                                                                                                                                 

  Genetic reagent (*D. melanogaster*)        UAS-LamDm0 RNAi                                                                            Bloomington            \#31605                

  Genetic reagent (*D. melanogaster*)        UAS-LamC RNAi                                                                              Bloomington            \#31621                

  Genetic reagent (*D. melanogaster*)        UAS-LamDm0-GFP                                                                             Bloomington            \#7376                 

  Genetic reagent\                           UAS-Pdm1-RNAi                                                                              Bloomington            \#55305                
  (*D. melanogaster*)                                                                                                                                                                 

  Genetic reagent (*D. melanogaster*)        UAS-Notch RNAi                                                                             VDRC                   \#27229GD \#100002KK   

  Genetic reagent (*D. melanogaster*)        UAS-Su(H) RNAi                                                                             VDRC                   \#103597KK             

  Genetic\                                   UAS-Dicer RNAi                                                                             VDRC                   \#24667GD              
  reagent (*D. melanogaster*)                                                                                                                                                         

  Genetic reagent (*D. melanogaster*)        UAS-Gro RNAi                                                                               VDRC                   \#6316GD               

  Genetic reagent (*D. melanogaster*)        'G-TRACE' (w\*; P{UAS-RedStinger}6, P{UAS-FLP.Exel}3, P{Ubi-p63E(FRT.STOP)Stinger}15F2.)   Bloomington            \#28281                

  Transfected construct\                     pChs-Gal4 vector                                                                                                                         *Hey* \> Gal4
  (*D. melanogaster* - S2 cells)                                                                                                                                                      

  Transfected\                               pUASp vector                                                                                                                             UASp-His-Hey
  construct (*D. melanogaster* - S2 cells)                                                                                                                                            

  Antibody                                   Mouse monoclonal IgG1 α-Prospero                                                           DHSB                   Prospero (MR1A)        1:100

  Antibody                                   Mouse monoclonal α-Armadillo                                                               DHSB                   N2 7A1 Armadillo       1:50

  Antibody                                   Mouse monoclonal α-Delta                                                                   DHSB                   C594.9B                1:50

  Antibody                                   Mouse monoclonal α 4F3 anti-discs large (Dlg)                                              DHSB                   4F3 anti-discs         1:50

  Antibody                                   Mouse monoclonal α−22C10                                                                   DHSB                   22C10                  1:20

  Antibody                                   Rabbit polyclonal α-HP1                                                                    Susan Purkhurst lab                           1:1000

  Antibody                                   Mouse monoclonal α-mTor                                                                    DHSB                   12F10-5F11             1:100

  Antibody                                   Rabbit polyclonal α-βGal                                                                   MP Biomedicals         55976                  1:500

  Antibody                                   Mouse monoclonal α-Actin                                                                   MP Biomedicals         691001                 (WB) 1:4000

  Antibody                                   Guinea pig α-Hey                                                                           [@bib67]                                      1:300

  Antibody                                   Rabbit α-Pdm1                                                                              Díaz-Benjumea lab                             1:50

  Antibody                                   Rabbit α-Fasciclin                                                                         Mikio Furuse lab                              1:100

  Antibody                                   Rabbit α-MESH                                                                              Mikio Furuse lab                              1:100

  Antibody                                   Rabbit α-SSK                                                                               Mikio Furuse lab                              1:100

  Antibody                                   Guinea Pig α-caudal                                                                        Jeff Reinitz lab                              1:200

  Antibody                                   Rar/Guinea Pig α-odd-skipped                                                               Jeff Reinitz lab                              1:100

  Antibody                                   Rabbit polyclonal α-p-histone H3                                                           Abcam                  ab5176                 1:100

  Antibody                                   Mouse α-Maelstrom                                                                          G. Hanon Lab                                  1:50

  Antibody                                   Mouse monoclonalα-γ-Tubulin                                                                Sigma                  T5326-200UL            (WB) 1:100

  Antibody                                   Mouse α Lamin C                                                                            Yossef Gruenbaum lab                          1:500

  Antibody                                   Mouse α Otefin                                                                             Yossef Gruenbaum lab                          1:10

  Antibody                                   Rabbit αLamin Dm0                                                                          Yossef Gruenbaum lab                          1:100

  Antibody                                   Rabbit α RecQ4                                                                             Tao-shih Hsieh lab                            1:100

  Antibody                                   Rabbit α-H3K4me1                                                                           Ali Shilatifard lab                           1:100

  Antibody                                   Rabbit α H3K4me2                                                                           Ali Shilatifard lab                           1:100

  Antibody                                   Rabbit α-H3K4me3                                                                           Ali Shilatifard lab                           1:100

  Antibody                                   Rabbit α-H3K27me3                                                                          Ali Shilatifard lab                           1:100

  Antibody                                   Rabbit polyclonal αH3K27Ac                                                                 Abcam                  ab4729                 1:100

  Antibody                                   Rabbit polyclonal α-H3K9me3                                                                Abcam                  ab8898                 1:100

  Antibody                                   Rabbit αNop60B                                                                             Steven Pole lab                               1:100

  Antibody                                   Rabbit α-LSM11                                                                             Joseph Gall lab                               1:2000

  Antibody                                   Guinee pig α-Coilin                                                                        Joseph Gall lab                               1:2000

  Antibody                                   Alexa Fluor 568 goat anti-mouse IgG1(γ1                                                    invitrogen             A21124                 1:1000

  Antibody                                   Alexa Fluor 568 goat anti-mouse IgG (H + L)                                                invitrogen             A11031                 1:1000

  Antibody                                   Alexa Fluor 568 goat anti-rabbit IgG (H + L)                                               invitrogen             A11036                 1:1000

  Antibody                                   Alexa Fluor 633 goat\                                                                      invitrogen             A-21070                1:1000
                                             anti-rabbit IgG (H + L)                                                                                                                  

  Antibody                                   Alexa Fluor 633 goat anti-mouse IgG1 (γ1)                                                  invitrogen             A-21126                1:1000

  Antibody                                   Alexa Fluor 568 goat anti-guinea pig                                                       invitrogen             A11075                 1:1000

  Antibody                                   Alexa Fluor 633 goat anti-guinea pig                                                       invitrogen             A21105                 1:1000

  Antibody                                   Alexa Fluor 633 goat anti-rat                                                              invitrogen             A21094                 1:1000

  Antibody                                   Alexa Fluor 568 goat anti-rat                                                              invitrogen             A11077                 1:1000

  Chemical compound                          Diamidino-2-phenylindole\*dihydrochl \[DAPI\] 1 mg                                         Sigma                  D9542-1MG              1:1000

  Chemical compound                          Draq-5                                                                                     Biostatus              BOS-889--001 R200      1:5000
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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Fly stocks used in this study {#s4-1}
-----------------------------

Fly stocks were maintained on yeast-cornmeal-molasses-malt extract medium at 18°C or as stated in the text. List of lines used is detailed under Supplemental Experimental Procedures. UASp-His-Hey was generated by cloning Hey cDNA with the addition of a 6xHis-tag into the pUASp vector. *w^-^, Hey*-Gal4;+;+was generated by cloning the 5'UTR proximal genomic region of *Hey* \[(-)1450-TSS\] into *pChs-Gal4* vector. This line was also used to generate the *w^-^*, *Hey*-Gal4, UAS-CD8-GFP/FM7;+;+line. Transgenic lines were generated by standard injection protocol using the appropriate primers. *w*: UASp-Hey; +, was generated by cloning the full cDNA of Hey to pUAS vector (Kpn/Xba) and transgenic lines were generated by injection in our lab.

Lines used for clonal analysis {#s4-2}
------------------------------

We generated FRT-Hey mutant chromosomes by standard recombination on the second chromosome: *pBac{WH}Hey^f06656^, P{neoFRT}42D pwn1 P{Car20y}44B/CyO* using Bloomington lines \#18997 and \#5260. The resulting line was crossed to *yw, hs-flp^122^, Tub-Gal4,UAS-GFP, FRT42D Tub-Gal80/Cyo (kind gift of Bruce Edgar)*, and for control we used a FRT 42D on the second. The relevant F1 progeny lines generated--y, w^-^, hs-flp^122^, *Tub-Gal4*, *UAS GFP*/+; FRT42D *Tub-Gal80*/FRT42D Hey*^f06656^* (experiment) and *y, w-, hs-Flp122*, *Tub-Gal4*, *UAS GFP/+*; FRT42D (control)-- were used for clonal analysis following [@bib1].

The following stocks were kind gifts received from various labs, as follows: *w; MyoIA-*Gal4; *tub*-Gal80ts, UAS-GFP; +, *w*; esg-Gal4, *tub-*Gal80ts UAS-GFP;+*w*; Prospero-Gal4 were from Bruce Edgar. *w; Dl-*Gal4/TM6, Tb and *Su(H)*-Gal4, and Notch-reporter 3.37-gh-LacZ were received from Sarah Bray. *10X-STAT*::GFP and *w; M5-4*::LacZ were received from Lilach Gilboa and Erika Matunis, respectively. UAS-LamC was received from Lori Walworth.

Gal4 for regional EC targeting: *y\* w\*;* P{w + mW.hs=GawB}NP0203/CyO,P{w-=UAS lacZ.UW14}UW14 (DGRC \#103555). Hey-RNAi knockdown lines: VDRC \#30562GD \#103570KK, Bloomington \#31898, \#41650. NIG-FLY: 11194 R-1, 11194 R-3. The following stocks were from Bloomington stock center: UAS-LacZ (\#1776); UAS-Hairy RNAi (\#27738, 34326); UAS-Her RNAi (\#27654); UAS-HLHm7 RNAi (\#35703, 29327); UAS-HLHm5 RNAi (\# 26201); UAS-CtBP RNAi (\#32889); UAS-Sir2 RNAi (\#32481), UAS-LamDm0 RNAi (\#31605), UAS-LamC RNAi (\#31621). UAS-LamDm0-GFP (\#7376). UAS-Pdm1-RNAi \#55305. The following stocks were from the VDRC stock center: UAS-Notch RNAi (\#27229), 100002); UAS-Su(H) RNAi (\#103597); UAS-Gro RNAi (\#6316). UAS-Dicer RNAi (\#24667) 'G-TRACE' transgenic line (\# 28281): w\*; P{UAS-RedStinger}6, P{UAS-FLP.Exel}3, P{Ubi-p63E(FRT.STOP)Stinger}15F2.

Cell line: Verified S2 *Drosophila* Schneider cells-DRSC (contributed by N. Perrimon) were obtained from DGRC and by DGRC similar to lot \#181 used for modENCODE studies. Cells were gown in S2 Schneider medium supplemented with 10% Fetal calf serum, Glutamine, and Penicillin/Streptomycin antibiotics. S2 cells cultured were grown in 25C0 and routinely tested and found to be mycoplasma-free by PCR.

Antibodies used in this study {#s4-3}
-----------------------------

### Primary antibodies {#s4-3-1}

Mouse α-Prospero (1:100), mouse α-Armadillo (1:50), mouse α-Delta (1:50), mouse α 4F3 anti-discs large (Dlg) (1:50), and mouse α−22C10 (1:20), and mouse IgG1 mouse IgG1 α-mTor (1:100) were all from DHSB; Rabbit α-βGal-55976 (1:500) and mouse α-Actin (1:4000) were from MP Biomedicals; Rabbit polyclonal α-HP1c (1:100) was a gift from Susan Parkhurst. Guinea pig α-Hey (1:300, [@bib67]) and rabbit α-Pdm1 (1:50) were a kind gift from Díaz-Benjumea; α-Fasciclin (1:100), α-MESH (1:100), and α-SSK (1:100) were a kind gift from Mikio Furuse. α-caudal (1:200) and α-odd-skipped (1;100) were from Jeff Reinitz; Rabbit α-p-histone H3 (1:100, ab5176) was from Abcam; Mouse α-Maelstrom (1:50) was a gift from G. Hanon Laboratory; Mouse α-γ-Tubulin (1:100) was from Sigma; Mouse αLamin C (1:500), mouse αOtefin (1:10) and rabbit αLamin Dm0 (1:100) were a kind gift from Yossef Gruenbaum; Rabbit αRecQ4 (1:100) was a gift from Tao-shih Hsieh. The following histone antibodies were a gift from Ali Shilatifard: Rabbit α-H3K4me1 (1:100), rabbit αH3K4me2 (1:100), rabbit α-H3K4me3 (1:100), and rabbit α-H3K27me3 (1:100). Rabbit αH3K27Ac (1:100) and rabbit α-H3K9me3 (1:100) were from Abcam. Antibodies for were form Rabbit αNop60B (1:100) was from Steven Pole, Rabbit α-LSM11 (1:2000), and Guinee pig α-Coilin (1:2000) were from Joseph Gall.

### Secondary antibodies {#s4-3-2}

Alexa Fluor 568 goat anti-mouse IgG1(γ1); Alexa Fluor 568 goat anti-mouse IgG (H + L); Alexa Fluor 568 goat anti-rabbit IgG (H + L); Alexa Fluor 633 goat anti-rabbit IgG (H + L); Alexa Fluor 633 goat anti-mouse IgG1 (γ1); Alexa Fluor 568 goat anti-guinea pig, and Alexa Fluor 633 goat anti-guinea pig (1:1000). Alexa Fluor 633 goat anti-rat, Alexa Fluor 568 goat anti-rat (1:1000). DNA dyes used: Draq5 (1:5000 889--001 R200, Biostatus) and DAPI (1:1000 D9542-1MG, Sigma).

Primers used in this study {#s4-4}
--------------------------

Hey-RNAi 5'-atccggaattccgaattaatacgactcactatagggctatcagccaaactgtgc

GFP-RNAi 5'- gaattaatacgactcactatagggtgagcaagggcgaggagctg

Methods {#s4-5}
-------

### Conditional expression of transgenes in specific gut cells {#s4-5-1}

Conditional expression of indicated transgenic lines in specific cells was obtained by activating a UAS-transgene under the expression of the indicated cell-specific Gal4-driver together with the tubGal80^ts^ construct ([@bib50]). Flies were raised at 18°C. At 2--4 days, F1 adults female progeny (and males in experiment depicted in [Figure 1---figure supplement 2A, B](#fig1s2){ref-type="fig"}), were transferred to the restrictive temperature 29°C (Gal80 off, Gal4 on) for two days unless indicated otherwise. Next, guts were dissected and analyzed as described below. At least three biological independent repeats were performed for each experiment. Where possible, we used multiple RNAi lines, as indicated below and in the figure legends. Specifically, in the case of Hey targeting, we used the following lines in specific experiments: [Figure 1](#fig1){ref-type="fig"}: G-H' VDRC\#103570, termed Heyi, I, I' NIG-FLY: 11194 R-1. Identical phenotype was also observed using NIG-FLY: 11194 R-3, and a line combining the Bloomington lines \#31898 and \#41650 (not shown). Figure S1 A-C' Heyi, D' NIG-FLY: 11194 R-1. [Figure 2](#fig2){ref-type="fig"}: Heyi, C, C', E, E'; 11194 R-1, D. [Figure 3](#fig3){ref-type="fig"}: 4: Heyi. and NIG-FLY:.

### Regional-Gal4 targeting in ECs {#s4-5-2}

The original description of this line is available at <http://flygut.epfl.ch/patterns/1086>. It is derived from the regulatory region of CG9003 that we did not identified as a Hey target. In addition to the published data, we further characterized the expression of this regional line and validated that it is only expressed in mature ECs, and that control targeted region is identical to non-targeted region (Figs. S7A-D). Quantification of this set of experiments was performed by comparing phenotypes of the targeted region to targeted region expressing LacZ control (Fig. S7Q).

*Conditional G-TRACE analysis* was performed using Myo-Gal4; G-TRACE flies were crossed to UAS-LacZ; Gal80^ts^ (control) or UAS-Hey-RNAi; Gal80^ts^ and the appropriate genotypes were raised at 18°C (a temperature at which no G-TRACE signal was detected). At 2--4 days, adult females were transferred to 29°C and linage tracing was performed.

*Paraquat treatment:* Where indicated, adult females were exposed for 48 hr to 5% sucrose solution with, our without, 5 mM paraquat similar to the treatment performed by [@bib19].

### Gut dissection and immunofluorescence detection {#s4-5-3}

Gut fixation and staining were carried out as previously described ([@bib84]).

### Clonal analysis of Hey-mutant clones {#s4-5-4}

The MARCM technique was used to study positively marked (GFP) *Hey^p^* mutant clones as described by [@bib1].

### Quantification by IMARIS and 3d reconstruction {#s4-5-5}

Z-stacks from Zeiss LSM 700 images were reconstructed into 3D images using IMARIS software (Version 8.3.0, Bitplane, Switzerland). Image analysis using a surface modulus algorithm was performed to measure the penetration depth of the cells. A single and representative midgut was used to reconstruct the 3D image of the cells. Blending calculations enabled to adjust the transparency of each channel (one channel per fluorophore), making it possible to view the composition of the structures. After generating a surface object, the same software automatically calculated a range of statistical parameters including surface area, volume, and DAPI and antibody intensity of the different midgut cells.

### Gut integrity and animal survival {#s4-5-6}

Two to four days old female flies from the specified genotype were collected into a fresh vial (10 flies per vial). All flies were kept in vials in a humidified, temperature-controlled incubator at 29°C. Flies were transferred into vials containing fresh food every two days and were scored for viability. Statistical analyses and overall survival curves were analyzed using GraphPad Prism software.

### 5mC-Chromatin Accessibility {#s4-5-7}

Females guts were dissected in Schneider medium, washed in PBS, and fixed in 6% EM-grade formaldehyde (Polysciences, Warrington, PA) diluted in PBS, with three volumes of heptane for 20 min. The dissected tissue was then washed with PBS, permeabilized using 0.5% Triton X-100 in PBS for 1 hr, washed with PBS three more times and blocked in PAT (1% BSA, 0.1% Triton X-100 in PBS (PBX) overnight. The next day, guts were washed twice with 250 µl M.SssI reaction buffer supplemented with 16 µM S-Adenosyl-L-methionine, Rre-suspended in 50 µl of M.SssI reaction buffer supplemented with 25U of M.SssI (NEB, Ipswich,MA) and 16 µM S-Adenosyl-L-methionine and incubated for 1 hr at 25°C on an orbital shaker. DNA was denatured by adding 1 ml of 2N HCl for 30 min at room temperature. The solution was then neutralized in 100 mM Borax for 5 min and washed twice with PBS. Detection of 5mC was performed using anti methyl-cytosine antibody primary antibody (monoclonal anti-5-mC, clone 33D3, Active Motif, Carlsbad, CA) that was added at 1 μg/ml. The next day, guts were washed three times with PBT (0.1% BSA, 0.1% Triton X-100 in PBS). We used secondary anti-mouse used Alexa-568 (1:1000) and DNA was visualized using DAPI for 1 hr and following two washes was mounted in Fluoromount-G for confocal imaging.

### DamID, expression signatures and bioinformatics analyses {#s4-5-8}

DamID was performed as described below, following [@bib79] and [@bib86].

### DamID chromatin profiling  {#s4-5-9}

Dam-Hey was generated by cloning Hey cDNA pNDamMyc vector to generate Dam-Hey (FL) and verified by western blot and immunostaining. DamID chromatin profiling was performed as previously described ([@bib6]; [@bib86]). Dam-methylated DNA was hybridized on NimbleGen DM2 CGH arrays with a probe spacing of \~300 bp ([@bib31]). DamID profiles for each Dam fusion protein were performed in duplicates, plus an additional dye swap technical replicate. Dam fusions were compared with methylase alone to control for non-specific accessibility. Microarray data was processed as previously described ([@bib38]; [@bib93]; [@bib94]). All data processing and analyses were performed using the R package for statistical computing (<http://www.r-project.org>). Data was LOESS normalized and a custom R script was implemented to define overlapping domains using a minimum 80% overlap threshold according to which at least one domain had to have at least 80% overlap with the other. We used parameter optimization functions within CGTools to determine the transition threshold and proportion of positive probe thresholds. Sharp transitions in the DamID signal were identified using a sliding edge filter (window size 199 probes) and adjacent transitions exceeding a threshold (here 0.3) were combined into domains if at least 70% of the enclosed probes had a positive log2 ratio.

### Purification and isolation of gut cells {#s4-5-10}

To isolate EBs we adopted a surface marking followed by magnetic cell purification protocol used to isolate border cells ([@bib96]). Specifically, *Hey-Gal4* \>UAS mCD8GFP virgin female flies were crossed (at 18 °C) to either UAS-GFP or UAS--Hey RNAi males. Two to four-day old female progeny were collected and aged at 18 °C for 2--10 days and then transferred to 29 °C for 2 more days prior to dissection. Purification protocol was carried out as previously described ([@bib96]). Enrichment was determined in each experiment using FACS and targeting was confirmed by immunostaining.

### RNA extraction, cDNA preparation, and gene expression analysis {#s4-5-11}

RNA was isolated in triplicate from independent fly crosses for each experiment and was prepared from purified cells according to the Qiagen RNeasy protocol. A total of 50 ng of total RNA sample was used as starting material to make cRNA probes followed by NimbleGen probe labeling. Double-stranded cDNA synthesis was carried out using Superscript III (Invitrogen 18080--051) followed by cRNA amplification using an Epicenter TargetAmp 1-Round aRNA amplification kit (TAU1R5124). Double-stranded cDNA was synthesized again and further labeled using a NimbleGen One-Color DNA labeling kit (05-223-555) and then hybridized to a *D. melanogaster* Gene Expression 4 × 72K Array (A4509001-00-01) according to the NimbleGen expression array protocol. Arrays were scanned using a GenePix 4000 microarray scanner and data was extracted using NimbleScan v2.4 software (Roche NimbleGen Inc, Madison, WI, USA). Microarray data was processed in NimbleScan using default settings. Data was further uploaded into the ArrayStar software version 3 (DNASTAR, Inc, Madison, WI, USA) for normalization and statistical analysis. A moderated t-test was performed with false discovery rate (FDR; Benjamini--Hochberg), and multiple testing corrections were applied on data (p\<0.05) with a 2-fold change or greater.

### Bioinformatics analyses {#s4-5-12}

LiftOver to dm3 was applied to all dm2 genomic data. End analyses (meta-analysis) were performed as described by [@bib23], using custom scripts in R or Galaxy/Cistrome ([@bib85]; [@bib60]). Visualization was carried out using the UCSC browser ([@bib53]). For Hey enrichment on states defined by [@bib31] and modENCODE (2010), Hey mean signal was averaged along each state/region and plotted as boxplot in R. Six thousand random sequences ranging between 2--5 Kb were generated in XLSTAT, considering a similar number of binding sites for regulatory elements revealed by [@bib31] and [@bib54]. Meta-analyses for histone modifications were performed by aligning all regions at their center and averaging the normalized mean probe values as a function of distance. Meta-analyses were performed on individual experiments, the signal was averaged, and the standard errors were calculated in Excel. Similar analyses were performed on all *Drosophila* Ref-seq genes at both their transcriptional start and termination sites ([@bib23]). Additional data source: Chromatin states defined by the modENCODE Consortium as well as Kc167 RNA-seq data were obtained from: [www.modencode.org/publications/integrative_fly_2010](http://www.modencode.org/publications/integrative_fly_2010), ([@bib33]); GSE22069 ([@bib31]).

### RNA-seq analysis of LamDm0 expression in ECs {#s4-5-13}

Four independent biological repeats were performed. Quality measurements for total RNA were performed using the TapeStation 2200 (Agilent). Library prep and data generation of RNA-sequencing: Starting with 100 ng total RNA, twelve RNA-seq libraries were produced using the NEBNext Ultra Directional RNA Library Prep Kit for Illumina (NEB, cat no. E7420), according to manufacturer\'s protocol. mRNA pull-up was performed using the Magnetic Isolation Module (NEB, Cat No. E7490). Two of the twelve libraries (Samples B1 and B2) were disqualified due to low library yield and high levels of adaptor dimer. Equal molar concentrations of the remaining ten libraries were mixed in a single test tube. The RNA-seq data was generated on two lanes of HiSeq2500, 50 SR. NGS QC, alignment and counting 50 bp single-end reads were aligned to *Drosophila* reference genome and annotation file (*Drosophila melanogaster*. BDGP6 downloaded from ENSEMBL) using TopHat (v2.0.13), allowing for two mismatches per read using the 'very-sensitive' option. The number of reads per gene was counted using Htseq (0.6.0).

For LamDm0 RNA-seq experiment and to generate descriptive and DEGs analysis: Sample clustering and differential expressed genes (DEGs) were calculated using Deseq2 package (version 1.10.1).

Gene ontology analysis of Hey DamID overlapping genes and mRNA expression was performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID <http://david.abcc.ncifcrf.gov/home.jsp>; v6.7 and v6.8) using default settings (2-fold p\<0.05 Benjamini P value for analysis E-03) ([@bib47]).

Biological processes with a p-value lower than 0.05 were further analyzed with Revigo ([@bib90]). Gene ontology analyses via Cytoscape: ClueGO app (v2.2.5) in Cytoscape (v 3.4.0) was used to conduct GO enrichment analyses. In our study, ClueGO was used to identify different functional groups in the following terms: Biological Process (BP), Cellular Component (CC) and Molecular Function (MF) enrichment analysis. A p-value≤0.05 was used as the cut-off criterion. In addition expression of transcriptional analyses were compared to gut specific signature obtained from flygut (<https://flygut.epfl.ch/expressions>).

*RNAi in S2 cells:* RNAi in S2 cells was performed as described by [@bib74].
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OrianAFlint-BrodslyNBitman-LotanE2018RNAseq analysis of whole Guts over expressing LaminDm0 or GFP in EnterocytesNCBI Gene Expression OmnibusGSE112640
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Decision letter

Bellen

Hugo J

Reviewing Editor

Baylor College of Medicine

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your work entitled \"The transcription factor Hey and nuclear lamins specify and maintain cell identity\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The reviewers have opted to remain anonymous.

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*. If you are able to address all the main issues raised by the reviewers we may consider a new version as a new submission.

*Reviewer \#1:*

The authors investigate the role of Hey, a bHLH transcription factor that is related to the Notch pathway, in differentiation of Enterocytes (EC) cells in the adult *Drosophila* midgut. Hey appears to play a Notch independent role, in maintaining the differentiation state of ECs. Following a combination of genetics, cell biological and bioinformatics methods, the authors conclude that Hey is crucial in mediating and maintaining EC differentiation (in addition to its context specific role in other cell types of the lineage, i.e. EB cells). The story culminates to the point where Hey regulates a developmental switch in lamins, lamDm0 and lamC, which are expressed in EBs and terminally differentiated ECs respectively. In fact the authors manage to show that:

a\) Lamins appear to share a network of target genes they coregulate with Hey, albeit they do so via a different mechanisms, i.e. by maintaining nuclear architecture as opposed to Hey maintaining Acetylation of histones and

b\) RNAi knockdown or overexpression of lamDm or lamC confirms the directionality of action in the lamins-Hey circuitry.

The manuscript is full of data, but the organization of the presentation was a bit difficult to follow. Nevertheless, the data are clear and they create new possibilities for future experiments. Indeed, the authors have managed to use existing tools and even make new ones (Hey MARCM stock, Hey Gal4, etc.) that can benefit their future studies as well as the studies of other groups looking into stem cell biology or maintanance of differentiation.

Major point:

Can the authors rescue Hey-RNAi phenotypes, such as the reduced survival and leakage of food in the abdominal cavity, by repressing laminDm or overexpressing lamin C?

Does overexpression of lamDm0 or repression of lamC cause phenotypes like Hey RNAi with regard to gut homeostasis, such as STAT reporters activity, Notch activity, upregulation of Dlg and Arm?

*Reviewer \#2:*

This study by Orian and colleagues examines phenotypic consequences of hey perturbation in the adult *Drosophila* midgut and transcriptional control by Hey in the midgut and in cell culture. The authors chief conclusions are that (1) Hey is a core terminal transcription factor for maintaining enterocyte identity and that (2) Hey executes this function by remodeling the nuclear architecture of enterocytes via control of lamin switching.

Overall, I feel that the data presented\--although substantial in volume\--unfortunately fall far short of providing convincing support for these conclusions. In my view, the revisions necessary to substantiate the authors\' claims would be quite a major undertaking.

My concerns involve what I see as significant issues regarding data interpretation and study design:

1\) Hey acts broadly in multiple cell types, but the study does not offer insight into how Hey achieves cell type-specific regulation. Specifically, Hey is expressed in all midgut cells and has pleiotropic roles in stem cells, enteroblasts, and enterocytes. Without knowing the mechanisms that underlie cell type specificity, I am not sure whether Hey is actually a core transcription factor or merely an accessory co-factor.

2\) A major element of the authors\' model is that the switch from LamDm0 to LamC during enterocyte differentiation produces widespread changes in gene expression by promoting different nuclear architectures. However, the study does not include any assessment of nuclear organization, lamina-chromatin association, or other lamin-influenced structural feature for any midgut cell type (either normal or genetically manipulated enterocytes and enteroblasts). As far as I can tell, the authors\' conclusions that Hey and LamC \"remodel the nuclear architecture\" and \"determine a nuclear organization that is unique to ECs\", although provocative, are not supported by either direct or indirect evidence.

3\) The datasets that are used to draw conclusions about cell type-specific transcriptional signatures and enhancer activity are not themselves specific to the relevant cell types.

a\) To isolate enteroblasts for microarray analysis (Figure 4A), the authors sort cells for UAS-GFP under control of a GAL4 driver comprising the 3\'UTR of hey. They state that this driver is expressed \"predominantly\" in enteroblasts. However, many Δ-expressing stem cells appear to express hey\>GFP (Figure S4A), and many cells that express hey\>GFP do not express the enteroblast-specific Notch reporter (Figure S4B). These features raise questions as to the specificity of the \"enteroblast\" datasets.

b\) Hey enhancer activity is inferred from DamID of cultured Kc167 cells, not of midgut cells. The authors state they were unable to perform DamID in midgut cells (although some precedents do exist: Korzelius et al., 2014, Loza-Coll 2014, Jin 2015, Chen 2018). Given that Hey has different targets in different cell types even within the midgut, it seems tenuous to extrapolate enhancer binding in Kc167 cells to midgut enterocytes.

4\) It is not clear to me that hey-knockdown enterocytes truly \"lose their differentiated identity\", as stated by the authors and as would be expected if Hey is a core terminal factor.

a\) Morphologically, the knockdown enterocytes still resemble enterocytes and not any other cell type.

b\) Physiologically, not evidence that enterocytes downregulate digestive enzymes or nutrient transporters or otherwise attenuate their digestive function.

c\) The phenotypic effects of hey knockdown (e.g. elevated JAK-STAT, expression of Notch reporters, loss of H3K27Ac, lamin mis-expression) appear partial, which is inconsistent with the notion that Hey is centrally important. (These partial effects do not appear to correlate with the extent of Myo1A driver activity, as far as I can gauge by co-expression of GFP in the images that are shown.)

d\) Many effects of hey knockdown resemble the well-characterized hallmarks of regeneration and ageing (e.g. elevated JAK-STAT, expression of Notch reporters, disorganization, leakiness). Indeed, I might interpret the hey knockdown phenotype as simply recapitulating the normal enterocyte response to damage and stress-not as wholesale reprogramming of enterocyte identity.

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for submitting your article \"The transcription factor Hey and nuclear lamins specify and maintain cell identity\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and K VijayRaghavan as the Senior Editor. The reviewers have opted to remain anonymous.

The manuscript went back for review to the previous reviewers but one reviewer was unable to re-review the manuscript. We therefore decided to send it out to another reviewer. Based on the comments of this reviewer we believe that upon making the suggested changes the manuscript may be suitable for publication. However, we would like to see a detailed rebuttal. The new reviewer provides many useful suggestions, particularly on data quantification and on the writing, that should be addressed.

*Reviewer \#2:*

The manuscript of Flint-Brodsly et al. is an exciting manuscript. The authors have improved the flow of the manuscript and strengthened their conclusions, by performing multiple additional experiments, while correcting the phrasing of certain points throughout the manuscript at the same time.

The manuscript describes the pleiotropic role of Hey TF in the *Drosophila* gut, focusing mostly on its role in the active maintenance of the differentiated state of the EC cells. The techniques the authors used range from genetic and cell biology experiments to multiple RNAseq and DamID experiments. The authors have addressed this reviewers\' remarks.

Additional data files and statistical comments:

A major problem that I have in evaluating this work is the general lack of quantification throughout the manuscript. The adult gut is a very dynamic tissue that responses rapidly to subtle environmental changes. Because of this, it is especially important that careful quantification be performed as it is very rare that any phenotype is black and white. Therefore, while there are some potentially interesting findings (changes in Lamins during differentiation; a role of Hey in EC LamC expression; potential regulatory roles for Lamins in controlling fate genes), it is impossible to judge from the data presented whether the anecdotal images are representative of all guts, all regions of the gut, males or females, etc. Ideally, all data should be rigorously quantified, with data points plotted\--not just an average, and compared with appropriate statistics. In particular, the effect on Pdm1 expression of Hey knockdown with Myo1AGal4 looks more subtle than some other phenotypes, which raises the issue of how direct or indirectly certain phenotypes are. Proper quantification of the data will make this more clear.

Another major issue that I have is that because the RNAi of Hey in ECs generates a proliferative response, many of the effects the authors detect could be secondary due to this. This should be addressed.

Finally, the paper could be more streamlined to improve readability. There are some things that seem irrelevant and could be removed (Figure 2E\', Figure 6S, T). Also, it seems to me that the characterization of the proliferative response in Figure 6 needs to come much earlier in the manuscript as it is important to interpret the rest. The \"hyperplasia\" is mentioned but not shown then or quantified.

1\) Quantification throughout, n= should be somewhere in legends or figures.

*--* Figure 1B-D. What% of cell types are marked by Hey?

*--* Figure 1E, E\', G, G\': How frequent is the large Dl+ cell phenotype. One example is shown- please quantify% of Dl+ cells that are Pdm1+. This phenotype might be linked to the proliferative state of the gut producing more newly made ECs. Their data do not show that the EC which downregulates Hey actually re-expresses Dl. Another hypothesis is that Hey knockdown in ECs triggers stress and activates ISC proliferation, in which conditions ISCs are known to be enlarged (for example upon yki overexpression, see Shaw et al., 2010, Figure 1H-J).

*--* Figure 1F, F\', H, H4- what% of ECs lose Pdm1 staining up Hey RNAi expression compared to controls? Can they co-stain with Hey to see if there is a direct relationship between Hey disappearance and Pdm1 disappearance?

*--* Figure 2 F, Figure 5I: the n should be put in the figure.

*--* Figure 3 D-G: What% of Dl+ cells express RecQ4 in Myo1A\>Hey RNAi and please compare to controls.

*--* Figure 4C, C\'; Figure 5A-B- Importantly a control is missing: the same region of guts expressing no RNAi. Due to the regional differences, I am not convinced one can compare across compartment boundaries like in the wing disc. Please add control and quantify% of cells altered for both.

*--* Figure 4D-G: These phenotypes could be due to differences in proliferation between HeyRNAi and wild-type. Newly produced ECs will inherit LacZ and may have more accessible chromatin. What does the LacZ line look like in wild-type MARCM clones that would similarly be proliferative tissue? In any event, these phenotypes need quantification.

*--* Figure 4I-CC; Figure 5G-Q: Please show the% of cells show these phenotypes, compared to controls, with stats.

*--* Figure 6: some quantification must be done here. The effect on MESH looks much stronger than the effect of Hey knockdown, in terms of% of ECs losing Hey. Why is this? Quantification of PH3 with \>15 guts.

*--* Figure 6UV: They state in the legend that 22% of flies have a smurf phenotype upon Hey RNAi. It would be helpful to write this on the figure so it is clear.

*--* Idem for the rest of the figures and supplementary figures.

2\) An important part of the manuscript is the finding that Lamin types switch from the progenitors to the EC and that Hey is required for maintenance of expression of the LamC in the EC. This finding seems to directly contradict recent data of Petrovsky and Großhans, 2018 that observe that LamC is uniformly expressed in the epithelial cells of the *Drosophila* intestine. What is the difference in experimental set up or interpretation? The authors should minimally discuss this contradictory finding that goes against their model.

3\) Important interpretations were made using GO term analysis. I am concerned that the results obtained are biased toward genes expressed in the ECs. My understanding is that when performing GO term analysis, the background gene set should be the expressed genes in the tissue or cell type. If this is not used, a bias will be obtained towards these genes since, the genes altered are those expressed in the tissue. The authors should use the background gene set from the gut epithelia plus surrounding muscle, which can be obtained at Flygut-seq for the analysis in Figure 3 and S8 to see if the categories of genes altered in HeyRNAi or LamDm0 overexpression are still statically enriched over the gene set of intestine genes (and not the whole genome).

4\) I feel that the authors overinterpret the data presented in Figure 2A-I\'. It is also written in a very confusing manner- please start by outlining the experiment and the expected results, then give the results without an interpretation of what the different colors of cells are. Then speculate on the potential meaning. They should not refer to the GFP+RFP- cells as \"no longer fully differentiated\". Similarly, do not refer to the RFP+GFP- cells as \"early ECs\" or the GFP-RFP- cells as \"potentially mis-differentiated\". These interpretations should be kept separate from the data and then substantiated with additional markers. A timecourse would be helpful as these populations should evolve over time. Also, given the difference in proliferation of control and knockdown, could the results be explained by altered kinetics in a regenerating gut? They could see if infection or damage conditions show a similar effect, which would argue against their model.

-Similarly, I believe they have misinterpreted the phenotype of Hey RNAi with respect to Notch signaling. Discussion, \"The ectopic activity of a Notch-reporter observed in EC-NFD upon Hey targeting in ECs suggests that Hey limits Notch activity in ECs.\" This is likely only due to a secondary effect on causing stress in the gut, driving ISC proliferation, and therefore making more, new EB cells that express the Su(H)-GBE reporter. It is unclear in the gut whether Hey has any impact on Notch signaling, is regulated by Notch, or is simply parallel.

5\) Did the authors show data of LaminC RNA decrease in S2 cells?

6\) \"These phenotypes were suppressed by over-expression of UAS-Hey, but not by a control transgene (Figures S1C, C4). Moreover, RNAi knockdown of Notch, Suppressor of Hairless, other HES TFs, and HES-related cofactors did not phenocopy Hey loss in ECs (Figures S2A-J).\"

-what phenotypes are being assessed. Please show some quantification.

7\) It should be clearly stated in the text that microarrays are used to assess transcriptomes. Quantification of the numbers of hey-Gal4 expressing cells should be done in the different backgrounds (controls vs heyRNAi). PCA plots should be shown.

8\) P7 \"Overall, the transcriptional signature of guts in which Hey was targeted in ECs largely resembled the signature of control purified progenitors\"

\- \"Hey knockdown was induced\" would be more clear

Also, it is not at all clear to me what is being compared here: is it the genes that change in Myo1A\>GFP vs Myo1A\>hey RNAi compared to the genes that are expressed in \"heyGal4+ cells\"? What are the heyGal4+ cells compared to? Whole guts? These are primarily EBs. The interpretation of these data are not clear to me? The microarray of whole gut while knocking down in ECs will give ISC, EB and EE genes altered in a non-autonomous fashion as well as EC genes altered.

9\) As mentioned above, quantification of the effects seen in Figure 4F-G; What% of guts show the effect? Figure 4 I-CC, what% of ECs show these effects? There is undoubtedly variability in these data- what is the level? Could these effects be due to different ages of EC cells? More new EC cells are likely made in Hey knockdown conditions- is it only new EC cells that show this? They could for example make MARCM clones and look at 3 day old ECS in wild-type to see if the chromatin marks are established or if they come during maturation of the EC.

10\) Figure 5G-I- they should also quantify what happens to Dl+ cells- here they lose both Dl+ cells and LaminDm0+ esg+ cells.

11\) The data in 5J are not convincing on their own. This does not look like Dl staining, which is usually vesicular. Please show some additional images and quantification. Similarly, 5M is not convincing: in this context, clearly there are more ISC divisions, leading to more esg+ cells, which are likely not all ISC/EBS, but newly produced ECs, which therefore express Pdm1. How do the authors identify progenitors in Figure 5M?

12\) PCA plots of the RNAseq data should be shown. They should state to what they are comparing the Myo1A\>LamD0 data (UAS-GFP?).

13\) I disagree with the following statement in the Introduction and Discussion, that I do not feel is supported by their references:

\"Indeed, multiple lines of evidence have established that failure to maintain a differentiated identity is a hallmark of aging...\" (Schwitalla et al., 2013; Deneris and Hobert, 2014; Ocampo et al., 2016)

To me, none of these references really strongly support the idea that differentiated cell fates decline during normal aging, which is what stated as fact. I would not say that this is a well-established notion. However, one paper that does support this is from the fly gut field and is not cited (Li, Qi and Jasper, 2016).

-In the Discussion section on Cell identity, aging, and pathological plasticity. \"During *Drosophila* and vertebrate aging, or under various stress condition, differentiated cells in the gut, pancreas, and trachael epithelium behave similarly, reflecting a general principle.\" While, I agree published data suggest plasticity in cancer or pathological cell loss in these tissues, a function of loss of identity during normal aging is less obvious to me and should be better supported by published literature. Mutant contexts such as Progeria syndromes are not equivalent to wild-type aging.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"The transcription factor Hey and nuclear lamins specify and maintain cell identity\" for further consideration at *eLife*. Your revised article has been favorably evaluated by K VijayRaghavan (Senior Editor), a Reviewing Editor, and two reviewers.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below. The proposed experiment at the end of this reviewers critique seems easy to do and should be informative.

*Reviewer \#3:*

The revised manuscript by Flint Brodsly and colleagues has been greatly improved. A major effort has been made to add much of the needed quantification.

However, I still feel that all of the effects described could be due to increased stem cell proliferation and rapid production of EC cells. The authors did not address this point of mine, instead of saying numerous times that this was outside of the scope of the manuscript.

For example:

\"Another major issue that I have is that because the RNAi of Hey in ECs generates a proliferative response, many of the effects the authors detect could be secondary due to this. This should be addressed."

*We fully agree. This is now better addressed including our G-TRACE analysis, as well as in the discussion. The potential cross-talk from ECs that lack Hey or LamC to progenitors or during aging is a broad topic that we are studying. I feel that the experimental molecular details; such as the identity of ligands secreted from ECs and that impinge and induce on progenitor regeneration is outside of the scope of this current manuscript (that is already dense), as these experiments will require at least six months (obtaining stocks and the subsequent genetics required).*

Also, given the difference in proliferation of control and knockdown, could the results be explained by altered kinetics in a regenerating gut? They could see if infection or damage conditions show a similar effect, which would argue against their model.

*Our manuscript focused on how ECs maintain identity, but rather in young adults or during normal aging. We strongly feel that how cell identity is maintained upon infection or DNA damage -- while highly interesting -- is outside of the scope of the present study.*

\- Similarly, I believe they have misinterpreted the phenotype of Hey RNAi with respect to Notch signaling. Discussion, \"The ectopic activity of a Notch-reporter observed in EC-NFD upon Hey targeting in ECs suggests that Hey limits Notch activity in ECs.\" This is likely only due to a secondary effect on causing stress in the gut, driving ISC proliferation, and therefore making more, new EB cells that express the Su(H)-GBE reporter. It is unclear in the gut whether Hey has any impact on Notch signaling, is regulated by Notch, or is simply parallel.

*The reviewer makes a good point. We have changed the text to better reflect this point:*

*\"The observed Notch-reporter activity in PPCs upon Hey targeting in ECs, may reflect stress-increased ISC proliferation and Notch activation in enlarged progenitors. Alternatively, this ectopic activity may suggest that Hey limits Notch activity in ECs.\"*

What I was suggesting that the authors do was not a six month experiment, but a simple treatment of flies with some damaging agent that induces a similar proliferative response to that seen upon Hey RNAi in ECs (one of: Ecc15, Pe, paraquat), and assess some of their nuclear phenotypes (LamC, LamDm0). If they do not see an impact on these marks, this would definitively rule out that the effect of Hey knockdown on ECs is merely indirect through rapid production of new ECs. For example, the effect on Arm that they find is also seen upon increased proliferation in the gut. Newly-made ECs upon rapid ISC proliferation are different from those made under homeostatic conditions. I do realize that this is extra work, but honestly, if this were my own paper, I would at least want to know this result and comment on whether or not this is likely indirect via proliferation stimulation. The alternative which may be more complicated genetically is to block proliferation in the Hey RNAi contexts and see if the effects on LamC or LamDm0 are still seen.

10.7554/eLife.44745.051

Author response

Reviewer \#1:

> The authors investigate the role of Hey, a bHLH transcription factor that is related to the Notch pathway, in differentiation of Enterocytes (EC) cells in the adult Drosophila midgut. Hey appears to play a Notch independent role, in maintaining the differentiation state of ECs. Following a combination of genetics, cell biological and bioinformatics methods, the authors conclude that Hey is crucial in mediating and maintaining EC differentiation (in addition to its context specific role in other cell types of the lineage, i.e. EB cells). The story culminates to the point where Hey regulates a developmental switch in lamins, lamDm0 and lamC, which are expressed in EBs and terminally differentiated ECs respectively. In fact the authors manage to show that:
>
> a\) Lamins appear to share a network of target genes they coregulate with Hey, albeit they do so via a different mechanisms, i.e. by maintaining nuclear architecture as opposed to Hey maintaining Acetylation of histones and
>
> b\) RNAi knockdown or overexpression of lamDm or lamC confirms the directionality of action in the lamins-Hey circuitry.
>
> The manuscript is full of data, but the organization of the presentation was a bit difficult to follow. Nevertheless, the data are clear and they create new possibilities for future experiments. Indeed, the authors have managed to use existing tools and even make new ones (Hey MARCM stock, Hey Gal4, etc.) that can benefit their future studies as well as the studies of other groups looking into stem cell biology or maintenance of differentiation.

We have extensively revised and re-wrote entire manuscript, simplified the presentation, reduced data load, revised supplemental figures and data. We were very strict on data interpretation. We have removed parts of the genomic data, that while interesting, distracted the reading flow.

> Major point:
>
> Can the authors rescue Hey-RNAi phenotypes, such as the reduced survival and leakage of food in the abdominal cavity, by repressing laminDm or overexpressing lamin C?
>
> Does overexpression of lamDm0 or repression of lamC cause phenotypes like Hey RNAi with regard to gut homeostasis, such as STAT reporters activity, Notch activity, upregulation of Dlg and Arm?

We have performed the suggested experiments:

1\) As expected, we demonstrate that perturbation in Lamin expression resulted in changes in gut homeostasis including ectopic activation of signaling pathway, as well as distinct changes in expression of cell adhesion molecules, loss of gut integrity and overall survival (New Figure 6). We specifically show that loss of LamC results in ectopic JAK-STAT activity, as well as expression of the stem cell related adhesion co-factor Armadillo (Arm), but had no effect on the expression of EC adhesion molecules like MESH. Inversely expression of LamDm0 in ECs resulted in reduced expression of EC genes like MESH but had no effect on Arm expression. We also show that expression of LamDm0 in EC, reduces the overall lifespan. Moreover we show that this regulation of lamins expression is impaired during aging. Remarkably, aging-dependent loss of LamC and the ectopic expression of LamDm0 are suppressed by over expression of Hey in ECs of aged flies (new Figure 7).

2\) Expression of LamC or elimination of lamDm0 each one by itself, or in combination was not sufficient to rescue the phenotype of loss of Hey. Since Hey is situated above the two lamins and act also directly on Pdm1, this inability is not surprising.The transcriptional activation by Hey of EC genes is mediated by itself and Pdm1, and therefore is not compensated by expression of LamC or loss of LamDm0 that act only on the repressive armof Hey activity.

3\) Moreover expression of LamC was not sufficient to inhibit the ectopic expression of Δ. we relate and describe this in the discussion: "Over-expression of LamC in Hey-targeted ECs was not, however, sufficient to repress ectopic Δ expression (data not shown), suggesting that the repressive activity of LamC may require the presence of Hey or a Heyregulated protein(s) on these gene regions." Thus, Hey activity is more broad than just the regulation of nuclear lamins, it is likely required for lamin-dependent repression and its activity is essential for both repression and gene activation

Reviewer \#2:

> \[...\] Overall, I feel that the data presented\--although substantial in volume\--unfortunately fall far short of providing convincing support for these conclusions. In my view, the revisions necessary to substantiate the authors\' claims would be quite a major undertaking.
>
> My concerns involve what I see as significant issues regarding data interpretation and study design:
>
> 1\) Hey acts broadly in multiple cell types, but the study does not offer insight into how Hey achieves cell type-specific regulation. Specifically, Hey is expressed in all midgut cells and has pleiotropic roles in stem cells, enteroblasts, and enterocytes. Without knowing the mechanisms that underlie cell type specificity, I am not sure whether Hey is actually a core transcription factor or merely an accessory co-factor.

We provide the following experimental evidence that Hey is a core transcription factor and not an accessory/redundant transcription factor:

1\) Loss of Hey in ECs cannot be compensated by the expression Pdm1.

2\) Increasing the amount of Hey by its Expression in stem cells represses the expression of ISC-specific genes like Δ and LamDm0 as well as likely promotes premature endoreplication. All features that are characteristics of differentiated ECs.

3\) Hey regulated genes in ECs and in Progenitors are very different with only minimal overlap, suggesting for specific hey-regulated signature in the different cells. (Figure 3H)

4\) As discussed for Rev.1 loss of LamDm0 or expression of LamC cannot suppress Hey phenotype. Taken together these data suggest that Hey has a key role in EC differentiation and is a pivotal transcription factor in maintaining EC identity. Thus, its activity is not "an accessory" cofactor, as suggested by the reviewer.

> 2\) A major element of the authors\' model is that the switch from LamDm0 to LamC during enterocyte differentiation produces widespread changes in gene expression by promoting different nuclear architectures. However, the study does not include any assessment of nuclear organization, lamina-chromatin association, or other lamin-influenced structural feature for any midgut cell type (either normal or genetically manipulated enterocytes and enteroblasts). As far as I can tell, the authors\' conclusions that Hey and LamC \"remodel the nuclear architecture\" and \"determine a nuclear organization that is unique to ECs\", although provocative, are not supported by either direct or indirect evidence.

The reviewer's criticism is correct. Therefore, in the current manuscript we have now extensively addressed this issue of large-scale organization of the EC nucleus upon Hey knockdown in ECs.

I\) We show that loss of Hey in EC resulted in increased global chromatin accessibility in ECs (new Figure 4).

II\) We show that loss of Hey affected global organization of EC nuclei (new Figure 4).

Specifically, we show:

I\) "We therefore investigated whether loss of Hey in ECs results in a global change in chromatin conformation using an M. SssI methylation-based chromatin accessibility assay (Figure 4F, G; Rincon-Arano et al. 2012). In brief, the M. SssI enzyme efficiently methylates CpG dinucleotides in vitro depending on chromatin accessibility. This methylation is endogenously minimal in differentiated somatic Drosophila cells. The methylated dinucleotides are subsequently detected using 5mCmAb (Bell et al., 2010). Only minimal 5mC methylation was detected in control gut ECs (9%, n=206), but upon Hey knockdown, a significant increase in 5mC was detected in polyploid cells using immunofluorescence with the 5mC antibody likely found in ECNFD or PMD cells (22% n=406; p\< 0.001) (Figure 4F, G and quantitated in Figure 4---figure supplement 3G)".

II\) "RNAi-mediated depletion of Hey resulted in impaired expression and distribution of heterochromatin protein 1c (HP1c), which was no longer localized to the chromocenter (Figure 4I, J). It also resulted in an increased distribution of Nop60B and Coilin, which mark the nucleolus and Cajal bodies, respectively (Figures 4K-N). We also observed impairment in the nuclear localization of LSM11 that is associated with the histone locus bodies (HLBs) (Figure 4O, P) and at the nuclear periphery, localization of Mtor, a nuclear envelope component, was distorted. Alongside changes in the expression of nuclear lamins (Figure 4Q-V). We observed reduced expression of Lamin C and increased expression of LamDm0. We also observed increased expression of the LamDm0 binding protein, Otefin, as well as its redistribution to the nuclear periphery (Figures 4W-X', 4H). In contrast, the immunofluorescence signal of the co-repressor dSin3A, which functions in HESmediated repression, was identical in both Hey-RNAi- and control-targeted gut (Figures 4Y, Z, Figure 1---figure supplement 3K, L)."

> 3\) The datasets that are used to draw conclusions about cell type-specific transcriptional signatures and enhancer activity are not themselves specific to the relevant cell types.
>
> a\) To isolate enteroblasts for microarray analysis (Figure 4A), the authors sort cells for UAS-GFP under control of a GAL4 driver comprising the 3\'UTR of hey. They state that this driver is expressed \"predominantly\" in enteroblasts. However, many Δ-expressing stem cells appear to express hey\>GFP (Figure S4A), and many cells that express hey\>GFP do not express the enteroblast-specific Notch reporter (Figure S4B). These features raise questions as to the specificity of the \"enteroblast\" datasets.

We agree with the reviewer that Hey-GAL4 drives expression also in ISCs (albeit to a much lesser amount that EBs). We therefore revised our statements and agree that this should be considered as a "progenitor driver". We now relate to these cells a "progenitors" and not purified EBs. We have extensively modified the text and data to accurately present the experiments, as well as their interpretation.

> b\) Hey enhancer activity is inferred from DamID of cultured Kc167 cells, not of midgut cells. The authors state they were unable to perform DamID in midgut cells (although some precedents do exist: Korzelius et al., 2014, Loza-Coll 2014, Jin 2015, Chen et al., 2018). Given that Hey has different targets in different cell types even within the midgut, it seems tenuous to extrapolate enhancer binding in Kc167 cells to midgut enterocytes.

We agree with the reviewer, and due to the concerns raised and in the current manuscript we do not discuss a potential role of Hey on enhancers. We also limited the discussion regarding the results of the DamID experiment. However for few genes that show binding in DamID, that we experimentally validated in ECs, and are important for ECs identity we show binding to predicted enhancer regions. These include genes like Pdm1, Δ, LamDm0, and LamC. Experimentally, we also show that the M5-4 enhancer reporter line of the stem cell esg gene that is active only in stem cells is ectopically activated in ECNFD (Figure 2 and Figure 5).

> 4\) It is not clear to me that hey-knockdown enterocytes truly \"lose their differentiated identity\", as stated by the authors and as would be expected if Hey is a core terminal factor.
>
> a\) Morphologically, the knockdown enterocytes still resemble enterocytes and not any other cell type.

While morphologically they still resemble polyploid ECs, a long the manuscript we bring evidences both by transcriptional analysis as well and using G-TRACE-confocal analysis that ECNFD fail to express many ECs specific genes including the key transcription factor Pdm1, EC specific adhesion molecules (Figure 2), and many putative digestive enzymes (S6). Moreover, these targeted ECs exhibit abnormal cell cycle phasing likely re-entering aberrant endoreplication visualized in vivo using an RGB cell cycle tracer line. For simplicity we did not relate to changes in cell cycle in the manuscript (see an example at end of point by point).

> b\) Physiologically, not evidence that enterocytes downregulate digestive enzymes or nutrient transporters or otherwise attenuate their digestive function.

We now show in Table S6 that more that 50 putative digestive enzymes are not expressed upon loss of Hey in ECs. This data is based with an extensive detailed excellent analysis of gut transcriptomics. In addition GO analysis of Hey downregulated genes show classical EC physiological groups such as transporters lipases, metabolic enzymes etc (Figure 3B, Table S2). We also show aberrant lysosomal activity using lyzo-tracker, and loss of gut integrity.

> c\) The phenotypic effects of hey knockdown (e.g. elevated JAK-STAT, expression of Notch reporters, loss of H3K27Ac, lamin mis-expression) appear partial, which is inconsistent with the notion that Hey is centrally important. (These partial effects do not appear to correlate with the extent of Myo1A driver activity, as far as I can gauge by co-expression of GFP in the images that are shown.)

The phenotype of loss of Hey are actually extremely strong. The gut structure is strongly affected and hard to dissect even after 72-100 h. Therefore we performed experiments after 48h hours. Under these experimental conditions many cells but not all lose identity as shown nicely in G-TRACE experiments (Figure 2). However as in many cases with RNAi this is not a null. Indeed using MARCAM we show that Hey deficient clones are hardly generated and they do not mature into full differentiated ECs. Thus, Hey is critical for establishing and maintaining EC identity, we therefore believe that the impression of the reviewer in this case is not correct.

> d\) Many effects of hey knockdown resemble the well-characterized hallmarks of regeneration and ageing (e.g. elevated JAK-STAT, expression of Notch reporters, disorganization, leakiness). Indeed, I might interpret the hey knockdown phenotype as simply recapitulating the normal enterocyte response to damage and stress-not as wholesale reprogramming of enterocyte identity.

We agree with the above criticism and in the current manuscript focused on aging. Indeed, we noticed that Hey protein levels in ECs decline with age (Figures 7A, B). Moreover, the phenotypes resulting from acute conditional knockdown of Hey in young flies (2-4 days old) are highly similar to the phenotypes observed in wildtype guts derived from aged flies (3-4 weeks old). As seen in NEW Figures 7C-J, aging ECs exhibit a reduction in the MyoIA-GFP signal, a decline in Pdm1 and LamC expression, along with ectopic expression of Δ and LamDm0 and overall reduced gut integrity (Figures 7C, 7E, 7G, 7I, 7K). Indeed, continued expression of Hey in aged ECs using MyoIAts-Gal4 prevented the ectopic expression of Δ and LamDm0 (Figures 7D, 7J), restored the expression of Pdm1 (Figures 7E, 7F), of LamC (Figures 7G, 7H), and of overall EC morphology, compared with control. Finally, expression of Hey prevented loss of gut integrity as revealed by the "smurf" assay (Figures 7K, 7L).Thus, we bring novel physiological role for Hey in maintaining aged dependent loss of EC identity.

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Reviewer \#2:

> The manuscript of Flint-Brodsly et al. is an exciting manuscript. The authors have improved the flow of the manuscript and strengthened their conclusions, by performing multiple additional experiments, while correcting the phrasing of certain points throughout the manuscript at the same time.
>
> The manuscript describes the pleiotropic role of Hey TF in the Drosophila gut, focusing mostly on its role in the active maintenance of the differentiated state of the EC cells. The techniques the authors used range from genetic and cell biology experiments to multiple RNAseq and DamID experiments. The authors have addressed this reviewer's remarks.
>
> Additional data files and statistical comments:
>
> A major problem that I have in evaluating this work is the general lack of quantification throughout the manuscript. The adult gut is a very dynamic tissue that responses rapidly to subtle environmental changes. Because of this, it is especially important that careful quantification be performed as it is very rare that any phenotype is black and white. Therefore, while there are some potentially interesting findings (changes in Lamins during differentiation; a role of Hey in EC LamC expression; potential regulatory roles for Lamins in controlling fate genes), it is impossible to judge from the data presented whether the anecdotal images are representative of all guts, all regions of the gut, males or females, etc. Ideally, all data should be rigorously quantified, with data points plotted - not just an average\-- and compared with appropriate statistics.

As detailed below we performed all the quantifications and statistics as suggested. As stated in the text, we have performed all the experiments in females. In addition, in the revised version we added analysis of Hey loss also in males (new Figure 1---figure supplement 2A, B), and show the impact of Hey loss on the entire gut (new Figure 1---figure supplement 2C-D'). Rigorous quantification is now presented along the entire manuscript.

> In particular, the effect on Pdm1 expression of Hey knockdown with Myo1AGal4 looks more subtle than some other phenotypes, which raises the issue of how direct or indirectly certain phenotypes are. Proper quantification of the data will make this more clear.

We quantified the data regarding Pdm1 at the protein level, and this is now shown in new Figure 1---figure supplement 1E. Please note that the reduction in Pdm1 expression was observed using different methodologies (global, and G-TRACE analyses of knockdown of Hey). Pdm1 was identified as a putative direct target of Hey by DamID (Hey binds to its predicted enhancer).

> Another major issue that I have is that because the RNAi of Hey in ECs generates a proliferative response, many of the effects the authors detect could be secondary due to this. This should be addressed.

We fully agree. This is now better addressed including our G-TRACE analysis, as well as in the discussion. The potential cross-talk from ECs that lack Hey or LamC to progenitors or during aging is a broad topic that we are studying. I feel that the experimental molecular details; such as the identity of ligands secreted from ECs and that impinge and induce on progenitor regeneration is outside of the scope of this current manuscript (that is already dense), as these experiments will require at least six months (obtaining stocks and the subsequent genetics required).

> Finally, the paper could be more streamlined to improve readability. There are some things that seem irrelevant and could be removed (Figure 2E\', Figure 6S, T). Also, it seems to me that the characterization of the proliferative response in Figure 6 needs to come much earlier in the manuscript as it is important to interpret the rest.

We improved the overall streamlining the paper. As suggested, we removed old Figure 6S, 6T (this experiment was added at the request of a reviewer in the first cycle of *eLife* revision).

> The \"hyperplasia\" is mentioned on p5 but not shown then or quantified.

As suggested we better present the data regarding hyperplasia including quantification shown in Figure 1J.

> 1\) Quantification throughout, n= should be somewhere in legends or figures.

All the quantification and "n" numbers were added.

> -- Figure 1B-D. What% of cell types are marked by Hey?

Hey is expressed in [all gut]{.ul} cells with high levels in EBs and ECs. We now added new Figure 1---figure supplement 1K-P that show the DAPI channel alongside endogenous Hey immuno-staining and cell specific markers demonstrating this and complementing the data presented in Figure 1.

> -- Figure 1E, E\', G, G\': How frequent is the large Dl+ cell phenotype. One example is shown- please quantify% of Dl+ cells that are Pdm1+.

We observed that 7-15%, of the polyploid cells to be positive for Dl and negative for GFP upon Hey knockdown this is now shown in Figure 1J'. Such cells are never observed in control. Unfortunately, double staining of Δ and Pdm1 cannot be performed as both antibodies are mouse monoclonal.

> This phenotype might be linked to the proliferative state of the gut producing more newly made ECs. Their data do not show that the EC which downregulates Hey actually re-expresses Dl. Another hypothesis is that Hey knockdown in ECs triggers stress and activates ISC proliferation, in which conditions ISCs are known to be enlarged (for example upon yki overexpression, see Shaw et al., 2010, Figure 1H-J).

In the revised version we better clarified this point and included the relevant reference. as correctly stated by the reviewer, polyploid cells (PPCs) that do not express GFP or RFP are likely mis-differentiated progenitors expressing Δ. Importantly, that G-TRACE analysis presented in Figure 2E' shows that it is the PPCs that are GFP (+) and RFP (-) (PPC \*\*) that express Δ on their surface. Based on the G-TRACE technique and since the expression of GFP is the result of a recombination event driven by active MyoGal4 (an activation that takes place only in the differentiated ECs), it is highly suggestive that PPC GFP(+) RFP(-) were EC initially, are currently not maintaining EC identity (hence are RFP negative) but express the GFP history marker.

> -- Figure 1F, F\', H, H4- what% of ECs lose Pdm1 staining up Hey RNAi expression compared to controls?

We observed that 82% of cells lose Pdm1expression upon targeting Hey. This is now presented in new Figure 1---figure supplement 1E (p\<0.0001, n (h) 784, n(c) 271).

> Can they co-stain with Hey to see if there is a direct relationship between Hey disappearance and Pdm1 disappearance?

We tried to perform the co-staining but technically this was not successful probably due to difficulties with both antibodies

> -- Figure 2 F, Figure 5I: the n should be put in the figure.

"n" entered into the figure.

> -- Figure 3 D-G: What% of Dl+ cells express RecQ4 in Myo1A\>Hey RNAi and please compare to controls.

We found that 17% of PPCs co-express Dl, RecQ4. These cells are not observed in control guts. A quantification is now shown in new Figure 3G'.

> -- Figure 4C, C\'; Figure 5A-B- Importantly a control is missing: the same region of guts expressing no RNAi. Due to the regional differences, I am not convinced one can compare across compartment boundaries like in the wing disc. Please add control and quantify% of cells altered for both.

Controls of regional targeting of Hey are now shown in Figure 4---figure supplement 2D, E and Figure 5---figure supplement 1A, B, and quantitative analysis in Figure 5---figure supplement 1C. In addition, we presented similar results using the MyoIA-Gal4ts system that acts globally in the midgut; demonstrating that loss of Hey resulted in reduction of H3AK27ac, LamC and increased expression of lamDm0 (see new Figure 4---figure supplement 3H-K, Figure 5---figure supplement 1F-I). As suggested Quantification of [all]{.ul} the regional experiment was performed in comparison to targeted region of control and is now shown in Figure 5---figure supplement 1C.

> -- Figure 4D-G: These phenotypes could be due to differences in proliferation between HeyRNAi and wild-type. Newly produced ECs will inherit LacZ and may have more accessible chromatin. What does the LacZ line look like in wild-type MARCM clones that would similarly be proliferative tissue? In any event, these phenotypes need quantification.

We agree with the reviewer, addressed this in the text, and show quantification in Figure 4---figure supplement 3E-G.

> -- Figure 4I-CC; Figure 5G-Q: Please show the% of cells show these phenotypes, compared to controls, with stats.

As suggested we added a detailed quantitative analysis with statistics. This is now shown in a table in new Figure 4---figure supplement 3L

> -- Figure 6: some quantification must be done here. The effect on MESH looks much stronger than the effect of Hey knockdown, in terms of% of ECs losing Hey. Why is this? Quantification of PH3 with \>15 guts.

Quantification of phosphoH3 is now shown Figure 6O. The impact on MESH is strong and maybe due to collapse of the entire structures between cells that impact MESH stability.

> -- Figure 6UV: They state in the legend that 22% of flies have a smurf phenotype upon Hey RNAi. It would be helpful to write this on the figure so it is clear.

\% is now written within the figures.

> 2\) An important part of the manuscript is the finding that Lamin types switch from the progenitors to the EC and that Hey is required for maintenance of expression of the LamC in the EC. This finding seems to directly contradict recent data of Petrovsky and Großhans, 2018 that observe that LamC is uniformly expressed in the epithelial cells of the Drosophila intestine. What is the difference in experimental set up or interpretation? The authors should minimally discuss this contradictory finding that goes against their model.

This paper was published after our manuscript was sent to review and therefore was not cited. In this work the authors identified that the expression of LamC in all cells based on the correlation with progenitor cells expressing the Esg-gal4 driver. This driver marks both EB and ISCs, but does not discriminate between them. This is in agreement with our observations that clearly show high levels of LamC in progenitors; low level in ISC and higher in EBs see Figure 4CC.

In the current version we relate and cite their work: "As our manuscript was under review Petrovsky and Großhans also characterized the expression of nuclear lamins in the midgut (Petrovsky and Großhans, 2019). Similar to our observations they reported that LamDm0 and Otefin are enriched in progenitor cells. They also reported the expression of LamC in progenitors cells. Our work using ISC and EB specific markers further established that in progenitors high levels of LamC are present in EBs and only minimal amount is expressed in ISCs."

> 3\) Important interpretations were made using GO term analysis. I am concerned that the results obtained are biased toward genes expressed in the ECs. My understanding is that when performing GO term analysis, the background gene set should be the expressed genes in the tissue or cell type. If this is not used, a bias will be obtained towards these genes since, the genes altered are those expressed in the tissue. The authors should use the background gene set from the gut epithelia plus surrounding muscle, which can be obtained at Flygut-seq for the analysis in Figure 3 and S8 to see if the categories of genes altered in HeyRNAi or LamDm0 overexpression are still statically enriched over the gene set of intestine genes (and not the whole genome).

As suggested we compared our gene expression data to the Flygut dataset to a "top hits per region" available at: https://flygut.epfl.ch/expressions. We find that the categories of genes altered in Hey RNAi or LamDm0 overexpression are still statically enriched over the gene set of intestine genes. We added this new data along the text and present it in Figure 3---figure supplement 4Q and Figure 5---figure supplement 3E.

> 4\) I feel that the authors overinterpret the data presented in Figure 2A-I\'. It is also written in a very confusing manner- please start by outlining the experiment and the expected results, then give the results without an interpretation of what the different colors of cells are. Then speculate on the potential meaning. They should not refer to the GFP+RFP- cells as \"no longer fully differentiated\". Similarly, do not refer to the RFP+GFP- cells as \"early ECs\" or the GFP-RFP- cells as \"potentially mis-differentiated\". These interpretations should be kept separate from the data and then substantiated with additional markers.

We agree with this correct suggestion and critic. We extensively revised this section in the text and relevant figures and show analysis with markers. we now call these cells PPCs (polyploid cells). We now refer to the GFP+RFP- cells as PPC\*\*, and GFP- RFP- as PPC\* and only at the end of the section we suggest interpretation based on the G-TRACE system.

> A timecourse would be helpful as these populations should evolve over time.

As suggested we show G-TRACE analysis within 24h and 48h time points. Quantification of this is presented in Figure 2---figure supplement 2A'-A".

> Also, given the difference in proliferation of control and knockdown, could the results be explained by altered kinetics in a regenerating gut? They could see if infection or damage conditions show a similar effect, which would argue against their model.

Our manuscript focused on how ECs maintain identity, but rather in young adults or during normal aging. We strongly feel that how cell identity is maintained upon infection or DNA damage -- while highly interesting -- is outside of the scope of the present study.

> -- Similarly, I believe they have misinterpreted the phenotype of Hey RNAi with respect to Notch signaling. Discussion, \"The ectopic activity of a Notch-reporter observed in EC-NFD upon Hey targeting in ECs suggests that Hey limits Notch activity in ECs.\" This is likely only due to a secondary effect on causing stress in the gut, driving ISC proliferation, and therefore making more, new EB cells that express the Su(H)-GBE reporter. It is unclear in the gut whether Hey has any impact on Notch signaling, is regulated by Notch, or is simply parallel.

The reviewer makes a good point. We have changed the text to better reflect this point:

"The observed Notch-reporter activity in PPCs upon Hey targeting in ECs, may reflect stress-increased ISC proliferation and Notch activation in enlarged progenitors. Alternatively, this ectopic activity may suggest that Hey limits Notch activity in ECs.".

> 5\) Did the authors show data of LaminC RNA decrease in S2 cells?

No, we have not analyzed mRNA levels of nuclear lamins in S2 cells (LamDm0 or LamC).

> 6\) \"These phenotypes were suppressed by over-expression of UAS-Hey, but not by a control transgene (Figures S1C, C4). Moreover, RNAi knockdown of Notch, Suppressor of Hairless, other HES TFs, and HES-related cofactors did not phenocopy Hey loss in ECs (Figures S2A-J).\"
>
> -- what phenotypes are being assessed. Please show some quantification.

We explained better the phenotypes in the text and showed quantifications (Figure 1J, J').

> 7\) It should be clearly stated in the text that microarrays are used to assess transcriptomes. Quantification of the numbers of hey-Gal4 expressing cells should be done in the different backgrounds (controls vs heyRNAi). PCA plots should be shown.

This is now stated in the Results section and not only in Materials and method section. PCA plots are presented in new Figure 3---figure supplement 4D, E and Figure 5---figure supplement 4.

> 8\) P7 \"Overall, the transcriptional signature of guts in which Hey was targeted in ECs largely resembled the signature of control purified progenitors\"
>
> -- \"Hey knockdown was induced\" would be more clear

As suggested we replaced this statement

> Also, it is not at all clear to me what is being compared here: is it the genes that change in Myo1A\>GFP vs Myo1A\>hey RNAi compared to the genes that are expressed in \"heyGal4+ cells\"? What are the heyGal4+ cells compared to? Whole guts? These are primarily EBs. The interpretation of these data are not clear to me? The microarray of whole gut while knocking down in ECs will give ISC, EB and EE genes altered in a non-autonomous fashion as well as EC genes altered.

We now better explain the gene expression experiment in the text. We also describe the potential alteration in gene expression due to non-autonomous effects.

> 9\) As mentioned above, quantification of the effects seen in Figure 4F-G; What% of guts show the effect? Figure 4 I-CC, what% of ECs show these effects?

As mentioned above we quantified all these phenotypes see Figure 4---figure supplement 3L.

> There is undoubtedly variability in these data- what is the level? Could these effects be due to different ages of EC cells? More new EC cells are likely made in Hey knockdown conditions- is it only new EC cells that show this? They could for example make MARCM clones and look at 3 day old ECS in wild-type to see if the chromatin marks are established or if they come during maturation of the EC.

We agree with the reviewer's point. However, it is still the case that Hey regulates chromatin accessibility during EC maturation and in its absence, chromatin is more accessible and adopts a more "open" structure. These effects are now quantified in Figure 4---figure supplement 3E-G.

> 10\) Figure 5G-I- they should also quantify what happens to Dl+ cells- here they lose both Dl+ cells and LaminDm0+ esg+ cells.

This quantification is now presented in revised Figure 5I where it is shown that only 10% of progenitors (Esg\>GFP+) that express Hey co-express Dl and LamDm0 compare to 100% in control

> 11\) The data in 5J are not convincing on their own. This does not look like Dl staining, which is usually vesicular. Please show some additional images and quantification. Similarly, 5M is not convincing: in this context, clearly there are more ISC divisions, leading to more esg+ cells, which are likely not all ISC/EBS, but newly produced ECs, which therefore express Pdm1. How do the authors identify progenitors in Figure 5M?

We replaced these figures with better representative images and show quantification in Figure 5T-W.

> 14\) PCA plots of the RNAseq data should be shown.

PCA data is shown in Figure 3---figure supplement 4D, E and Figure 5---figure supplement 4.

> They should state to what they are comparing the Myo1A\>LamD0 data (UAS-GFP?).

Indeed, this is the case and it is now clearly stated in the text.

> 15\) I disagree with the following statement in the Introduction and Discussion, that I do not feel is supported by their references:
>
> \"Indeed, multiple lines of evidence have established that failure to maintain a differentiated identity is a hallmark of aging...\" (Schwitalla et al., 2013; Deneris and Hobert, 2014; Ocampo et al., 2016)
>
> To me, none of these references really strongly support the idea that differentiated cell fates decline during normal aging, which is what stated as fact. I would not say that this is a well-established notion. However, one paper that does support this is from the fly gut field and is not cited (Li, Qi and Jasper, 2016).

As suggested we revised the text: "Indeed, failure tomaintain a differentiated identity is associated altered physiological properties of post-mitotic cells and tissues resulting in disease such as diabetes, neurodegeneration, and cancer (Deneris and Hobert, 2014; Ocampo et al., 2016). We also added the relevant reference (Li, Qi and Jasper, 2016)".

> -- In the Discussion section on Cell identity, aging, and pathological plasticity. \"During Drosophila and vertebrate aging, or under various stress condition, differentiated cells in the gut, pancreas, and trachael epithelium behave similarly, reflecting a general principle.\" While, I agree published data suggest plasticity in cancer or pathological cell loss in these tissues, a function of loss of identity during normal aging is less obvious to me and should be better supported by published literature. Mutant contexts such as Progeria syndromes are not equivalent to wild-type aging.

We revised the text:

"One well-studied case is that of human LamC ortholog, LamA, which is mutated in Progeria, a disease associated with premature aging and loss of physiological properties of differentiated cells and tissues (Hegele, 2003). However, further studies are needed in order to link loss of identity and premature aging in progeria models and patients, to the consequences of physiological aging. Therefore, the identification of conserved mechanisms underlying the regulation of identity networks in model organisms such as *Drosophila* has broad implications for addressing pathological conditions in humans, and specifically age-related diseases."

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Reviewer \#3:

> "The proposed experiment at the end of this reviewers critique seems easy to do and should be informative". "What I was suggesting that the authors do was not a 6 months experiment, but a simple treatment of flies with some damaging agent that induces a similar proliferative response to that seen upon Hey RNAi in ECs (one of: Ecc15, Pe, paraquat), and assess some of their nuclear phenotypes (LamC, LamDm0). If they do not see an impact on these marks, this would definitively rule out that the effect of Hey knockdown on ECs is merely indirect through rapid production of new ECs...I do realize that this is extra work, but honestly, if this were my own paper, I would at least want to know this result and comment on whether or not this is likely indirect via proliferation stimulation.

As suggested we performed the experiment that is now shown in new Figure 5---figure supplement 2I-P. We have evaluated the changes in expression of LamC, lamDm0, and Mtor upon exposure to paraquat, that induces a rapid proliferative response.

We have performed this experiment using MyoIA \>GFP marking ECs, and similar to the experiment where we knockdown Hey using Hey RNAi. Paraquat treatment resulted in progenitors proliferation and formation of polyploid cells. However unlike in the case of targeting Hey, or during aging, the ECs in the gut retained the expression of MyoIA-GFP as well as LamC. They did not ectopically express LamDm0. Nor did they show changes in the expression of Mtor. Thus, this experiment strongly suggest that the effect observed upon loss of Hey is directly affecting ECs, and not merely reflecting only proliferative stimulation of progenitors.

We now added in the text:

"Importantly, the changes observed in LamC, LamDm0, expression and nuclear organization (such as localization of Mtor), were not observed upon paraquat exposure, that induces rapid progenitor proliferation (Figure 5---figure supplement 2I-P; Chatterjee et al., 2009). Thus, these changes are directly related to loss of Hey supervision in ECs".

[^1]: These authors contributed equally to this work.
